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Background: South Asians demonstrate high coronary heart disease mortality, largely 
unexplained by conventional risk factors and unidentified by risk stratification tools.  
Developments in technology allow us to visualize coronary atherosclerosis non-invasively, 
thus providing the potential to identify presence of coronary atherosclerosis before it 
manifests clinically. Coronary artery calcification is closely correlated with total plaque 
burden and provides an assessment of coronary plaque burden. Myocardial perfusion 
scintigraphy provides an estimate of myocardial blood flow and thus, severity of coronary 
artery disease. Increased coronary artery calcification and silent myocardial ischemia predict 
future risk of coronary heart disease mortality, independent of conventional factors.  
Inflammation is a key factor in initiation and progression of atherosclerosis. High sensitivity 
C-reactive protein (CRP) is an important marker of active inflammation and is considered an 
independent predictor of future cardiovascular events. Thus, markers of subclinical 
atherosclerosis and inflammation could provide us with a tool for early identification of 
South Asians at risk of coronary events, unidentified by traditional means.  
However, majority of the data for such markers is from North American and 
European populations, with no data evaluating the role of coronary artery calcification, 
myocardial perfusion scintigraphy and CRP in assessing the coronary heart disease risk in 
South Asians. 
 
Methods and Results:  I carried out assessments including coronary artery calcium, 
myocardial perfusion imaging and assessment of high sensitivity C-reactive protein for a 
cohort of asymptomatic South Asians and Europeans men and women, aged 35 to 75 years, 
who were part of the London Life Sciences Population (LOLIPOP) study. I found that: 1) 
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Coronary artery calcification scores were closely associated with age, male gender, cigarette 
smoking, hypertension, systolic blood pressure, diabetes and total cholesterol. 2) There were 
no differences in either coronary artery calcification prevalence or mean levels of coronary 
artery calcification between South Asians and Europeans, after adjustment for the measured 
cardiovascular risk factors. 3) Presence of diabetes and increasing coronary artery 
calcification were independent predictors for silent myocardial ischemia. 4) South Asian 
ethnicity did not influence the prevalence or the extent of silent myocardial ischemia, after 
adjustment for conventional risk factors. 5) C-reactive protein levels did not correlate with 
measures of plaque burden. 5) South Asian ethnicity was an independent predictor of 
inflammation as seen by levels of high sensitivity C-reactive protein. This effect was 
independent of, and remained significant after adjusting for conventional cardiovascular risk 
factors and novel factors linked to inflammation such as diabetes and indices of abdominal 
obesity.  
  
Conclusions: While traditional risk factor correlate well with markers of 
atherosclerosis, the higher coronary heart disease risk and mortality observed in South Asians 
is not identified by markers of atherosclerotic burden such as coronary artery calcification 
and myocardial perfusion scintigraphy. South Asians have elevated levels of inflammation as 
seen by high sensitivity C-reactive protein levels. C-reactive protein levels are not correlated 
with coronary artery calcium or myocardial ischemia measured by myocardial perfusion 
scintigraphy. These findings suggest a role of factors such as systemic and plaque 
inflammation, unrelated to and unmeasured by plaque burden assessment in the higher 
coronary heart disease mortality observed among South Asians. The study therefore suggests 
a role of potential risk stratification tools reflecting the multisystem nature of CHD. These 
could be a combination of clinical risk factors contributing towards CHD, imaging of 
atherosclerotic plaque and assessment of plaque or systemic inflammation. 
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Chapter 1: Introduction 
 
1.1 Coronary Heart Disease among South Asians 
 
1.1.1 Coronary Heart Disease Epidemiology 
 
Coronary heart disease (CHD) is the single largest contributor to global mortality, 
with more than 13% of the total deaths (7 million), attributed to it in 2002 (1). There are, 
however, distinct ethnic disparities in the incidence and mortality due to CHD. South Asians 
(people originating from the India, Pakistan, Bangladesh and SriLanka) demonstrate a high 
CHD attributed mortality. Data from the WHO (2002) demonstrated that this group 
contributed a quarter of the global CHD deaths, about the same number of CHD deaths as all 
the developed countries from Europe and America combined (1) (Figure1.1). South Asians 
currently constitute 22% of the global population and as a result of a high  growth rate are 
expected to increase this proportion to 28% by 2050 (2). As a consequence of an increasing 
population with a high inherent CHD risk, South Asians are expected to contribute a 
staggering 40% of the global CHD burden by 2050 (2).  
Among South Asians there appears to be a gradation of CHD risk which correlates 
with the level of urbanization. A study using analysis of ECG Q waves demonstrated a 4-5 
fold higher prevalence of CHD in urban India compared with rural India (3) and data from 
countries such as Fiji, Singapore, USA, Trinidad and UK have demonstrated higher CHD 
mortality among South Asian migrants compared with native populations (3-10). Thus, it 
appears that there is increasing CHD mortality with the level of urbanization; with the 
greatest risk amongst South Asians living overseas. 
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Within the UK, South Asians formed the largest ethnic minority group and make up 
4% of the total population (2001 population census). Improved healthcare and health 
awareness over the last 3 decades has significantly decreased CHD related mortality in the 
general population in the UK, with CHD mortality rates of 132.0/100,000 for the period 
from1993-2003. South Asians within the UK, however, continue to show a 2-fold higher 
CHD mortality rate (241.0/100,000) for the same period. (4).  
Due to lack of prospective data regarding CHD risk and mortality in South Asians, the 
reasons for this excess remain poorly understood.  
 
1.1.2 Conventional risk factors 
Large scale prospective studies such as the Framingham cohort have identified 
important risk factors for CHD including hypertension, hyperlipidaemia, low HDL, smoking 
and increasing age. One limitation of studies so far is the predominantly Caucasian base 
population. This potentially limits their use in other ethnic populations. However, recent 
global registries such as INTERHEART (5), carried out among multi ethnic populations, 
suggest an important role for conventional risk factors in CHD across different ethnic groups.  
Existing data for migrant South Asians demonstrates that despite high CHD rates 
among South Asians subgroups; they do not consistently exhibit elevated levels of 
conventional risk factors (6,7). For example, among migrant South Asians the level of serum 
cholesterol, hypertension, as well as cigarette smoking rates in some cases can be equivalent 
to, or lower than a comparable Caucasian population (8-10). This risk factor prevalence is in 
contrast to the high CHD mortality, leading to the belief that conventional risk factors do not 
contribute to the high CHD mortality rates observed among South Asians (9). 
However, observational studies performed among Asians demonstrate that serum 
cholesterol, blood pressure, smoking rates, and body mass index are substantially higher in 
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urban compared to rural Indians (11). This is consistent with their higher CHD prevalence 
(3). Similarly, overseas South Asians demonstrate higher prevalence of conventional risk 
factors as well as a higher CHD prevalence compared with their non-migrant siblings (12). 
Within the UK, South Asians demonstrate higher mean blood pressure levels, compared with 
Europeans (9,13). Cigarette smoking is observed to be twice as common in Bangladeshis (6), 
and the prevalence of hypertension increased two-fold in Sikhs (11), compared with 
Europeans.  
Thus, it is clear that the conventional risk factors are relevant in pathogenesis of CHD 
among South Asians. However, given the lack of consistency in prevalence of risk factors 
among various South Asian subgroups, and indeed compared with Europeans, the question 
whether such risk factors explain the excess risk of CHD seen in this population remains 
unanswered.   
 
1.1.3 Diabetes Mellitus and related metabolic disorders 
Type 2 diabetes mellitus is a well-known risk factor for CHD, with associated 
accelerated atherosclerotic disease and higher rates of cardiovascular morbidity and mortality 
compared with non diabetics (14). The risk from diabetes is considered to be as high as that 
attributed to a history of previous coronary event i.e. it is considered a CAD ‘risk equivalent” 
(15) 
South Asians demonstrate a high prevalence of non-insulin dependent diabetes. 
Reported figures suggest prevalence of 2-5% in rural, 5-10% in urban, and almost 20% in UK 
South Asian, compared to 4% prevalence of diabetes among European men (6,16-21). 
Furthermore, South Asians demonstrate a higher prevalence of insulin resistance and its related 
metabolic abnormalities (elevated glucose levels, central obesity, glucose intolerance, elevated 
plasma insulin, increased triglycerides, raised PAI-1, and reduced high-density lipoprotein 
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cholesterol), compared with Europeans populations (6,9,11,22).  The reasons for this higher 
prevalence in South Asians are not clear, and there are several theories postulated: 
i) Genetic susceptibility and lifestyle changes  
South Asians appear to have genetic predilection for diabetes (23,24), as well as 
metabolic abnormalities such as high triglycerides (25), abdominal obesity and insulin 
resistance (26). Furthermore, there appears to be positive correlation with the level of 
urbanization. While the prevalence of diabetes is approximately 2% in rural settings, it rises 
dramatically to as much as 5-10% in urban communities within India (16,18,27). Exposed to 
a greater level of urbanization, such as that seen among South Asian immigrants to the 
Western world, this increase is even more apparent. In the United Kingdom, the prevalence 
of diabetes in South Asians approaches 15% to 20%, markedly higher than the 4% diabetes 
prevalent among Europeans (6,12,20,28).   
Among South Asians, urbanization and growing income has been seen to be 
associated with an excess calorific intake. This is in part due to excess sugar and fat 
consumption, coupled with decreased physical activity and sedentary way of life (28,29), and 
leads to obesity. The increased prevalence of obesity can potentially explain to the greater 
blood pressure (30) , increased prevalence of diabetes (21,31) and the increase in serum 
insulin, insulin secretion and decreased insulin sensitivity (32). 
 
ii) Low birth weight  
There appears to be an increased prevalence of insulin resistance and obesity 
observed among low birth weight babies. This is hypothesized to be due to a poor maternal 
nourishment causing an adaptive state in the foetus for survival under such conditions, both 
ante and postnatal (33). Such changes become harmful when the postnatal environment is 
different from that predicted antenatal, i.e. over abundant nutrients and consequent obesity. 
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The risk of future disease is thus greatest amongst those that subsequently become obese 
during adult life (34,35).  
Previous studies illustrate that children of low birth weight have increased CHD 
mortality in later life (34,36,37). Low birth weight has been linked with an increased risk of 
hypertension, diabetes, insulin resistance, dyslipidaemia, with elevated hsCRP and fibrinogen 
levels in later life (38,39). However, the main contributing factor to the risk of CHD in this 
population is deemed to be insulin resistance and the risk of diabetes.  
South Asian babies are small compared to other populations with an average weight 
of a newborn native Indian at 2.7kg, 3.1kg in UK South Asians, 3.4kg in Caucasians, and 
3.7kg in North American Indians (40-43). Furthermore, previous studies have demonstrated 
higher insulin levels at birth for South Asians babies, compared with Europeans, after 
adjusting for birth weight.  
Observations that the prevalence of CHD is almost 4-fold higher amongst Indians 
with birth-weight <2.5kg, compared a birth-weight >3.2kg (37), support the theory of low-
birth weight and its sequelae contributing to excess CHD risk amongst South Asians.  
  Thus, the genetic predilection coupled with the change in lifestyle increases the risk 
for developing an insulin resistant state or the metabolic syndrome (44), with the attached 
high CHD risk among South Asians ethnicity.  
While the prevalence of diabetes has been demonstrated to be higher among South 
Asians (45,46), compared with Europeans; studies from the UK and Canada have 
demonstrated diabetics South Asians have an almost 2 fold higher risk of cardiovascular 
events compared with European diabetic subjects even after adjusting for other 
cardiovascular risk factors (9,47). The cause of this excess is as yet completely elucidated and 
it therefore seems plausible that risk factors other than the previously considered ones play an 




1.1.4 Novel risk factors 
 
i) Inflammation 
Atherosclerosis has often been termed as a chronic inflammatory process (48). 
Inflammation is one of the key factors in initiating atherosclerosis and is instrumental in 
pathogenesis of vulnerable plaques (49,50).  
Inflammation causes damage to the endothelial membrane, resulting in increased 
endothelial adhesiveness and permeability allowing increased LDL entry into arterial intima. 
Furthermore, the endothelial damage causes release of cytokines and growth factors whose 
chemotactic nature stimulates monocyte-derived macrophages and T lymphocytes 
accumulate at the site of injury. Inflammation is thought to play a critical role in predisposing 
to plaque rupture by destabilization of the fibrous cap tissue, triggering majority of the 
episodes of coronary thrombosis (48). This is supported by studies done in animal models as 
well as those among human cases of sudden death, demonstrating increased macrophage 
activity in plaques which underwent rupture and subsequent thrombosis (51). Furthermore, 
recent studies in human subjects have shown markedly increased inflammation within active 
atherosclerotic plaques in carotid arteries (52,53). 
South Asians exhibit a high prevalence of diabetes, hypertension, abdominal obesity 
and metabolic syndrome, with lower HDL cholesterol levels (54-57). Presence of these risk 
factors is associated with greater systemic inflammation (58,59).  In addition, South Asians 
also demonstrate elevated levels of C-reactive protein (CRP) (60). This is consistent with 
experimental studies which suggest that abdominal adipose tissue is a major source of 
cytokines, including IL-6, an important determinant of hepatic CRP synthesis (61,62).  
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  CRP is an important marker of inflammation, with elevated levels of CRP strongly 
associated with increased macrophage activity within plaques (63,64), and is considered an 
independent predictor of future cardiovascular events (51,65). Increased concentrations of 
CRP have been shown in both clinical and epidemiological studies to be associated with 
atherothrombotic events. 
   These observations suggest a higher level of systemic inflammation, as well as 
inflammatory activity within plaque, amongst South Asian compared with Europeans. Thus, 
it raises the possibility that inflammatory mechanisms contribute at least in part, to the 
increased risk of CHD amongst South Asians. 
 
ii) Homocysteine and risk of CHD in South Asians 
  Homocysteine is a sulphur-containing amino acid, increasingly recognised as an 
independent risk factor for vascular disease (66,67). The mechanisms are not well elucidated; 
however, studies indicate that they could be mediated through an action on the endothelium. 
Studies in man show that elevated plasma homocysteine concentrations are associated with 
impaired endothelium-dependent vasodilatation, an early manifestation of atherosclerosis 
(68). Furthermore, in vitro studies demonstrate that prolonged exposure of cultured 
endothelial cells to homocysteine impairs nitric oxide mediated inhibition of platelet 
aggregation (69,70) as well as specific proinflammatory cytokines associated with migration 
recruitment of leukocytes across
 
the vascular endothelium (71) 
   Recent studies have demonstrated higher concentrations of plasma homocysteine 
among South Asians compared with Europeans (9,22,72).  Thus it is thought that elevated 




iii) Endothelial dysfunction 
 The vascular endothelium is an integral part of the atherosclerotic cascade. A normal 
endothelium maintains homeostasis through a variety of mechanisms which include control 
of vascular tone, smooth muscle cell proliferation and migration, along with effects on 
thrombogenesis and fibrinolysis (73,74). Endothelial dysfunction is an early manifestation of 
atherosclerosis, preceding plaque formation, and evidence of angiographic disease.  
  One of the important mediators for the endothelium is nitric oxide (75), which plays 
an important role in maintaining vascular integrity by modulating vascular tone, enabling 
endothelial repair (76), inhibiting thrombosis and leukocyte adhesion, and by influencing 
smooth muscle cell proliferation (77). Studies have demonstrated that brachial artery flow 
mediated dilatation is largely mediated by nitric oxide released by the endothelium (76), and 
is inhibited by L-NMMA (75).   
 While endothelial damage and resulting dysfunction normally occurs due to damage by 
free radicals generated by various toxic stimuli, endothelium dependent dilatation is impaired 
even among healthy UK South Asians compared to Europeans (75,78). Several explanations 
for the impaired endothelial function among South Asians have been postulated, including 
the elevated levels of homocysteine and early atherosclerosis; however, the exact mechanism 
remains unknown and the dysfunction is unexplained by conventional atherosclerotic risk 
factors (78).  Thus, endothelial dysfunction due to reduced activity of endothelial nitric oxide 
could be a significant contributor to vascular injury in South Asians.   
 
iv) Lipoprotein (a) 
 
Lipoprotein (a), formed from the assembly of the protein apolipoprotein (a), has 
been identified as an independent risk factor for vascular disease, including CHD (79,80). 
Though the exact mechanisms underlying this relationship are uncertain, in vitro studies 
suggest that lipoprotein (a) may influence cholesterol uptake and inhibit fibrinolysis (79).  
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Serum lipoprotein (a) concentrations are being determined at birth by variations in the 
LPA gene. Lipoprotein (a) concentrations are reported to be higher in South Asians 
compared to Europeans, reflecting the high CHD risk in this racial group (12) 
 
v) Psychosocial and economic factors 
 Stress has been considered an important risk factor for CAD. The two most 
recognised components of this are socio-economic and psychosocial stress. These encompass 
a variety of things including low income, poor education, poor job prospects, stress at work 
and home, overcrowding in household, racial discrimination and social support.  Such factors 
have been shown to be associated with CAD, a role which has been further emphasised by 
the INTERHEART registry (5). INTERHEART, which was a global registry, concluded that 
stress factors could be account for up-to 32.5% of the population attributable risk for MI. 
This, to put in context, was only slightly less than the population attributable risk for lifetime 
smoking (35.7%), and more than that for hypertension (17.9%) or obesity (20.0%). While 
INTERHEART was a cross sectional observational study, and the effect is yet to be proven in 
a prospective cohort, nevertheless the study highlights the possible importance of such 
factors.  
 There are three plausible ways in which stress can affect health. First, stress may 
affect health related behaviours such as smoking, diet, alcohol consumption, or physical 
activity, which in turn may influence the risk of coronary heart disease (81-85). This is thus 
by exposing to known pathogens. Second, it may influence access to and content of medical 
care. This is more relevant in a healthcare system which is not state funded and there is no 
free access to healthcare (86,87). Third, stress may cause direct pathophysiological changes 
i.e. direct causal effect. 
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 While the first two concepts are fairly self explanatory, a number of mechanisms have been 
proposed to explain the direct pathological effect of stress in CAD. These include activation 
of the sympathetic nervous system, endothelial dysfunction causing release of 
proinflammatory cytokines and prothrombotic responses which in turn promote atherogenesis 
and plaque rupture (88-90). These factors may act independently or have a cumulative effect. 
 South Asians score poorly on measures of psychosocial stress i.e. higher levels of 
chronic stress, depression, lower levels of social support and demonstrated lower socio-
economic status (91). South Asians are also more likely to live in areas with increased social 
and economic deprivation (92). In addition, studies have also suggested variability in access 
to healthcare among UK South Asians compare with the local European population.  While it 
appears that South Asians might seek earlier medical advice for symptoms suggestive of 
angina (93), regional studies suggest that South Asians may be less likely to be referred for 
further investigation and referrals (94-96). The poor access to healthcare, however, is not 
supported by contemporary studies, at least in the UK, which suggest comparable access to 
healthcare for South Asians compared with Europeans (97,98). Thus within the UK, South 
Asians appear to exhibit at least a few if not all of the stress components related to CAD. 
 Stress has been demonstrated to be correlated to measures of subclinical 
atherosclerosis such as CAC (99) and silent myocardial ischemia (100), as demonstrated by 
our group among others. Therefore, in order to assess the role of such factors in CHD among 
South Asians, our study also conducted a comprehensive psychosocial assessment on a 
proportion of the participants. The psychosocial assessment was divided into measures of 
chronic stress, protective factors in the social environment, psychological factors and health 
behaviours. Univariate and multivariate regression analysis were then preformed to predict 
the presence and extent of calcification, using these factors.   
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The results from our study demonstrated that South Asian and European groups have 
marked differences in psychological characteristics, with higher hostility and depression 
scores seen among South Asian.  In UK South Asian men, the only predictor for presence of 
CAC in univariate analysis was age of finishing education, however once behaviours were 
adjusted for, this was reduced to non-significance.  In UK South Asian women, the indicators 
of socio-economic status, household consumables and social deprivation, were negatively 
associated with presence of CAC on univariate analysis.  The association between 
consumables and CAC was no longer significant once social deprivation had been taken into 
account. Even after adjustment for health behaviours and adiposity, social deprivation was 
negatively related to presence of CAC. 
In European men, social deprivation was positively associated with presence of CAC, 
independent of age and other risk factors.  In European women, the work stress variables of 
work demands, effort-reward imbalance, and job strain were positively related to presence of 
CAC, even after controlling for age, health behaviours, and adiposity.  This suggested that 
elevated levels of work stress in European women were associated with an increased risk of 
coronary calcification and CHD.   
Analysis for the extent of CAC demonstrated that job demands and effort were 
positively related to the extent of CAC in South Asian men, independent of age and other 
confounding variables. In European men, hostility emerged as having a strong association 
with the extent of CAC, and this effect was not attenuated by adjustment for health 
behaviours such as smoking, BMI and WHR.   
Thus while psychosocial factors were related to CAC, the effect was variable among 
Europeans and South Asian participants and not necessarily in the direction expected. While 
stress appears to be associated with a higher incidence of acute coronary events (101-103) 
and coronary ischemia (104), and while South Asians are more exposed to stress; measures of 
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stress are not consistently related to CAC i.e. calcified plaque. This is due to a complex 
interplay of factors including systemic inflammation, plaque characteristics and 
neuroendocrine activation which mediate the cascade of atherosclerosis. Thus the measures 
of plaque burden alone are poorly correlated with risk due to stress.  
Thus South Asians have a combination of biological, psychosocial and lifestyle 
factors, the combination of which is likely to be responsible for their excess CHD.  
 
1.2 Risk stratification/ Screening for coronary heart disease 
 
1.2.1 Traditional risk stratification for CHD 
CHD is a complex disease with a multifactorial aetiology. The effect of sum of risk 
factors is therefore not necessarily linear but often exponential i.e. the risk of CHD due to the 
presence of two risk factors is not twice that a single risk factor, but can be three, four times 
or higher. Thus, while it is important to assess and address individual risk factors, 
identification of the total burden of risk is extremely important. Risk assessment is often 
considered the key step in effective management of clinical risk and does so by differentiating 
low from high risk patients, and thereby identifying those that would benefit most from 
aggressive risk factor management. The rationale underlying the balance between treatment 
intensity and patient risk being the greater benefit of drug exposure when the patient’s risk is 
high. 
In view of the high mortality and morbidity from CHD, and the importance of early 
identification of subjects at high risk of cardiovascular events, several risk stratification tools 
have been formulated to calculating risk of CHD incidence and mortality. These include 
Framingham, FINRISK and SCORE among others (105,106).  Majority of these equations use 
conventional risk factors including age, gender, hypertension, smoking and hyperlipidaemia to 
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calculate a medium to long term risk of CHD event. While the factors implicated in clinical 
coronary events as discussed in the previous section i.e. plaque burden, plaque morphology and 
systemic factors, are to an extent a downstream effect of the CHD risk factors, it is known that 
while calculating a risk proportion for the general population is a great variation of observed 
CHD risk within each stratum (107). Thus, there is still a large amount of risk left unaccounted 
for by such tools. Furthermore, while these equations have accurately predicted CHD risk in 
Caucasian populations, they fail to accurately estimate the risk in South Asians (108,109).  One 
important reason for inaccurate estimation in diverse ethnic groups is that the baseline date used 
to create these risk stratification tools is from a predominantly Caucasian population. This has 
several crucial implications:  first, risk equations take into account the baseline CHD risk in a 
population and then add the effect of each risk factor to formulate an overall risk score and 
therefore predictions. Since the baseline CHD risk differs among ethnic groups any and any 
calculation which does not take this into account will be not provide accurate estimates. Second, 
as demonstrated by INTERHEART (5), the relative effect of risk factors differs among ethnic 
groups, i.e. there is a large variation in the relative importance of risk factors.  Thus the 
percentage risk attributed to an individual risk factor while formulating the equations is likely to 
differ. Furthermore, most risk stratification tools use a categorical representation of risk factors 
i.e. cut offs for risk factors such as hypertension, blood sugar levels etc. While these cut off 
points are in themselves chosen arbitrarily even for the Caucasian population, these might be 
poor in assessing the risk in an ethnic population.  
Third, the risk factors which were seen as significant among the baseline population i.e. 
Caucasians, were incorporated. These might not reflect the risk among diverse ethnic 
populations. While impaired vascular endothelial function(78), raised C-reactive protein 
(60,110), elevated homocysteine (22) and lipoprotein (a)(9,12,111) are known risk factors for 
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CHD, and are more prevalent amongst South Asians than Europeans, they are not accounted 
for in the assessment of CHD risk using these equations.  
In order to accurately identify the overall risk for CHD mortality, the pathophysiology 
of atherosclerotic coronary plaques, as well as the pertinent local and systemic factors must 
be taken into account in addition to the standard risk factors. 
28 
 
1.3  Pathophysiology of coronary heart disease  
 
1.3.1 Atherogenesis:   
 
i. Initiation: 
The main pathological feature in coronary artery atherosclerosis is the atherosclerotic 
plaque, which develops following a complex interaction between inflammation, cell necrosis 
and deposition of lipid within the arterial wall (48,112-115) (Figure 1.2). Endothelial 
dysfunction secondary to damage by free radicals generated by factors such as smoking, 
diabetes, hypertension and elevated LDL is often considered as the initial step in formation of 
plaque (48). This endothelial damage results in increased endothelial adhesiveness and 
permeability allowing increased LDL entry into arterial intima. In addition, the endothelial 
damage causes release of cytokines and growth factors whose chemotactic nature stimulates 
monocyte-derived macrophages and T lymphocytes accumulate at the site of injury. These 
macrophages engulf the LDL, and activate the hallmark foam cells of atherosclerosis.   
Once the endothelium is damaged, it activates a self sustaining cascade. Activated 
macrophages, T lymphocytes and oxidized LDL stimulate further release of inflammatory 
cytokines, chemokines, and growth factors which in turn stimulate migration and 
proliferation of smooth-muscle cells, as well as hydrolytic enzymes. Such enzymes can 
induce further damage and focal necrosis, and cell death (116). The end result of this cascade 
of events is accumulation of foam cells, migration and proliferation of smooth-muscle cells, 
and the consequent formation of fibrous tissue over the necrotic lipid rich core. This leads to 
formation of the characteristic atherosclerotic plaque. 
Atherosclerotic plaques are further categorised into early and advanced lesions, 




ii. Early atherosclerosis 
The density and distribution of the foam cells and the lipid particles is used to divide/ 
separate early atherosclerosis into three stages: 
1. Type I lesion: This lesion consists of the first microscopically and chemically 
detectable lipid deposits in the intima and the cell reactions associated with 
such deposits. It characteristically consists of foam cells dispersed in small 
groups within the arterial intima along with minimal amount of lipid deposits.  
2. Type II lesion (fatty streak): It is the first grossly visible lesion in the 
development of atherosclerosis. The lesion characteristically consists of 
macrophage foam cells forming stratum, rather than isolated groups. Also 
present in this stage are lipid-rich intimal smooth muscle cells, and a thin layer 
of extracellular lipid present in the intima. As it often appears as an irregular 
off white to yellow-white discoloration near the luminal surface of the artery, 
it is also called as the “fatty streak”. 
3. Type III lesion (preatheroma):  This lesion is characterised by the 
presence of multiple extracellular lipid pools which lie below the layers of 
macrophages and macrophage foam cells. The lipid layer replaces intercellular 
matrix proteoglycans and fibres, and drive smooth muscle cells apart. As this 
stage lacks a well-delineated lipid core characteristic of an advanced 
atheroma, it is also named the “preatheroma”. 
 
iii. Advanced atherosclerosis:  
Atherosclerotic lesions are considered advanced when accumulations of lipid, 
cells and matrix components, occur in association with intimal disorganization and 
thickening, deformity of the arterial wall. Such lesions are often associated with 
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complications such as fissure, hematoma, and thrombosis. Advanced lesions may 
produce symptoms, but the lesions that precede them are clinically silent. 
Histologically, this is further divided into 3 stages:  
4. Type IV lesion:  This lesion is characterised by a presence of a thin 
intima and a large lipid core. It is considered to be the first atheroma or 
advanced atherosclerotic plaque and often forms the “thin cap fibroatheroma”. 
The plaque at this stage contains macrophage foam cells and isolated smooth 
muscle cells between the lipid core and the lesion surface, with none or 
minimal fibrous tissue.   
Such lesions are the most likely culprits in acute plaque rupture through 
disruptions of the lesion surface, haematoma or haemorrhage, and thrombotic 
deposits (51,117).   
5. Type V lesion: These lesions are formed after repeated subclinical rupture of 
plaque followed by healing and formation of fibrous tissue along with 
calcification. While the composition of the type V lesion can vary depending 
on the presence or absence of calcification and size of lipid core; type V 
lesions are generally more fibrosed and narrowed compared with type IV 
lesions with fibrous connective tissue in the intimal layer.  
6. Type VI lesions are further subdivided according to the culprit pathology i.e. 
haemorrhage, fissures or thrombosis. While type VI lesions generally have the 
underlying morphology of type IV or V lesions, surface disruptions, 
haematoma, and thrombosis may be (although less often) superimposed on 




The lesions that constitute the histopathological classification are perceived as 
characteristic gradations or stages that span the transition from initial minimal changes to 
lesions associated with clinical manifestations. The resulting classification thus reflects the 
temporal history of the disease. In the early stages of atherosclerosis the sequence is 
predictable, and uniform, but advanced lesions may progress in different sequences, resulting 
in several characteristic lesion types and clinical syndromes. This depends as much on plaque 
burden, as on plaque morphology and composition.  
 
1.3.2 Plaque burden and morphology 
 
While a large coronary plaque burden portents obstructive coronary artery disease, 
studies now show suggest that lesion composition and morphology is a better predictor of 
clinical outcome than severity of stenosis (117,118).  It has been observed that a high 
percentage of acute coronary events occur in vessels with angiographically moderately 
stenosis  (119). Furthermore, the recent studies using IVUS in subjects known to have <50% 
stenosis of the coronary arteries by angiography, demonstrated bulk of new coronary events 
associated with lesions that were eccentric and contained relatively shallow but prominent 
echolucent zones suggestive of large lipid collections (120). They were similar in luminal 
obstruction to the plaques which remained stable, i.e. did not go on to have an acute event 
(121).  
Histopathological and IVUS examination of atherosclerotic plaques associated with 
acute coronary events show two-thirds of acute events result from the rupture of the thin 
macrophage rich fibrous cap. The rupture of this thin inflamed fibrous cap exposes the 




These features support the concept that plaques that are prone to rupture demonstrate 
outward remodelling at the site of culprit lesions rather than luminal encroachment causing 
angiographically visible stenosis and have several important implications.  
First, due to different remodelling patterns i.e. negative versus positive remodelling 
seen among coronary arteries with stable CAD versus acute coronary syndrome, angiography 
cannot necessarily risk stratify subjects well. Second, and more importantly, the 
thrombogenic potential of a plaque depends to a large degree on the composition of the 
underlying lesion or intima, as well as modifications of shear and tensile forces to which the 
lesion or intima is exposed, rather than presence of advanced stenosis.   
 
1.3.2  Emerging modalities for risk assessment  
 
As discussed in previous sections, the risk of symptomatic clinical coronary events is 
an amalgamation of multiple risk factors. These include a) The degree of intra luminal 
coronary obstruction due to plaque burden, as well as plaque surface (123,124), b) plaque 
characteristics/ morphology which can act as local thrombogenic agents (125), c) systemic 
risk factors and thrombogenecity (126). 
Plaque vulnerability can be quantified by the assessment of its morphological features 
such as thinning of the plaque cap, presence of a large lipid core, evidence of fissured plaque 
and a luminal stenosis >90%. While this has been traditionally through the assessment of the 
coronary arteries using invasive techniques such as intravascular ultrasound; the importance 
of assessment of atherosclerosis burden rather than individual plaque characteristics is also 
being recognised by means of non-invasive techniques (127,128). Modalities such as electron 
beam computed tomography allow detection of calcification within the coronary arteries, and 
thus quantify the atherosclerosis burden therein.  
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Arterial disease is rarely confined to one vascular bed, thus, ultrasonography of the 
carotid or an accessible peripheral artery, has been used to provide an insight into disease in 
the cerebral or coronary vasculature; a “pan arterial” assessment that represents subclinical 
peripheral, cerebral and coronary vascular disease. Moreover, assessments of plaque 
morphology undertaken in a peripheral artery are thought to be reflective of plaque 
characteristics coexisting in the coronary or cerebral vascular territories. The concept of 
plaque instability existing simultaneously in multiple vascular beds has been described and 
echolucent carotid plaques have been shown to be strongly and independently associated with 
future coronary events in patients with stable CHD (120).  
While anatomical detection of atherosclerosis and quantifying plaque morphology is 
important, it is equally important to evaluate blood thrombogenecity and systemic 
inflammation, identification of the “vulnerable patients” (127), as opposed to just vulnerable 
plaque. Serum markers of atherosclerosis (abnormal lipoprotein profile), inflammation (high-
sensitivity CRP) , metabolic disorders (blood glucose, triglycerides and homocysteine) and 
through coagulation disorders (fibrinogen, factor V Leiden, increased coagulation factors, 
decreased anticoagulant factors), are thus important factors in assessing CHD risk. 
However, in the absence of large scale population studies demonstrating the prognostic 
ability of many of the risk factors, they cannot be assimilated into population based risk 
stratification equations. As technology has advanced one possible improvement to such 
equations has been revealed in the form of ability to visualize coronary atherosclerosis and its 





1.3.3 Sub clinical atherosclerosis 
 
Traditional epidemiological studies have been instrumental in developing the concept of 
cardiovascular risk factors and cardiovascular risk stratification. This is mainly through risk 
factors association with adverse outcomes such as death or myocardial infarction. However, 
there has been considerable interest in moving away from large, outcome based studies to 
smaller studies that use measures of subclinical atherosclerosis as their primary endpoint.  
Studies based on such measures of atherosclerosis have several intrinsic advantages. It is 
much easier to examine the subclinical phase of atherosclerosis, when treatment or interventions 
have the most potential for altering the natural history of atherosclerotic disease. Treatment 
effects and behavioural changes are less likely to complicate interpretation of study results. 
Measurement of subclinical disease can enhance studies of CHD risk and prevention by allowing 
examination of its early stages, with other subclinical markers as well as associative factors. 
Finally, since measures of subclinical atherosclerosis are generally quantitative, the power to 
define risk associations is much improved when compared to outcome studies that use 
dichotomous end-points, that is, presence or absence of disease.  
Thus, such studies have a potential to not only enhance the understanding of the disease 
process, but also risk assessments. 
 
1.3.4 Imaging subclinical atherosclerosis  
Imaging techniques can detect subclinical CHD by either directly visualising the 
anatomical presence of arterial disease using markers such as coronary artery calcification 
imaging or by measuring the effects of disease processes through functional techniques such as 
myocardial perfusion imaging.  
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 Coronary artery calcification has been demonstrated to be an integral part of the 
atherosclerotic plaque by histopathological studies (129) and shows excellent correlation with 
total plaque burden (130) (Figure 1.3). Furthermore, numerous studies over the last decade have 
demonstrated the independent prognostic information provided by coronary artery calcium 
measurement in predicting CHD mortality, after adjustment for conventional risk factors. This  
thus  identifies the actual “at risk” population and improve the predictive ability of risk 
stratification models i.e. subjects with high levels of coronary artery calcification have more 
events than those without even with the same prevalence of other CHD risk factors (131-135).  
While coronary artery calcification imaging identifies presence of plaque and overall 
plaque burden, it does not allow quantification of obstructive coronary disease.  Thus, while 
subjects at a higher risk of CHD are identified, the hemodynamic relevance and the resulting 
ischemic burden of the detected atherosclerotic lesions cannot be quantified.  Myocardial 
perfusion imaging is a technique which has been validated for functional assessment of flow 
limiting lesions within coronary arteries.  
Myocardial ischemia as quantified by myocardial perfusion imaging has been shown to 
add prognostic benefit independent to known coronary anatomy in subjects with known 
coronary artery disease; as well as to risk assessed by traditional risk factors and risk factor 
equations among asymptomatic subjects (136-140).  
At a population level, however, as the prevalence of silent myocardial ischemia varies 
according to the characteristics of the patient population screened, the prevalence of perfusion 
defects is understandably low in low risk asymptomatic populations with increasing prevalence 
as the risk of CHD increases. Thus, the importance of perfusion imaging is in delineating 
presence of flow limiting disease in subjects at a high risk of CHD. This risk could be quantified 
either through use of risk stratification equations or direct visualization of coronary plaque 
through calcium imaging.  
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Several studies have demonstrated the use of coronary artery calcium imaging as a 
screening test for presence of atherosclerotic plaque, with further quantification of flow limiting 
coronary disease through myocardial perfusion imaging (141,142).  There appears to be an 
increase in prevalence and extent of ischemia with increasing coronary calcium. Furthermore, 
these studies have demonstrated a greater mortality in subjects with higher levels of silent 
ischemia, with absence of inducible ischemia has been shown to identify subjects with very low 
(<1% per year) risk of coronary events (143) further supporting the rationale of such an 
approach. Thus a sequential imaging strategy using initial CAC imaging followed by selective 
MPI, combines the advantage of high sensitivity of CAC imaging with the specificity of MPI for 
predicting angiographic stenosis, thereby improving assessment of a high risk population for 
future CHD events (141).  
37 
 




There have been different views regarding the mechanism of calcium deposition in 
the atherosclerotic plaques. While calcification was initially considered a passive process of 
adsorption or precipitation and merely a secondary effect of advanced atherosclerotic 
degenerative processes; recent studies indicate that atherosclerotic calcification is an 
organized, active process which is mediated and regulated by various biological factors 
(130,144) such as apoptosis of smooth muscle and foam cells, calcification-regulating 
proteins and lipoproteins.  
Apoptosis of smooth muscle cells and macrophages-derived foam cells is considered 
to be a critical trigger event in intimal vascular calcification (145), through formation of 
matrix vesicles (146). Apoptotic bodies along with organelle-remnants from intimal vascular 
smooth muscle cells serve as nucleation sites for calcification. In vitro studies have 
demonstrated inhibition and stimulation of vascular calcification in cell cultures of human 
vascular smooth muscle cells (147), to be intrinsically affected by inhibition and stimulation 
of apoptosis. These observations further strengthening the argument for a role of apoptosis in 
calcification 
Calcification-regulating proteins such as osteopontin, matrix Gla protein phosphatase 
and bone sialoprotein appear to play an important role of in the process of atherosclerotic 
calcification. They are expressed by vascular smooth muscle cells, as well as by certain 
subsets of macrophages within plaque (148-150). Presence of osteopontin in atherosclerotic 
plaque and its absence in normal arteries without atherosclerosis (151), along with its co-
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localization with sites of early calcification in the plaque, provide support for the role of such 
factors in vessel wall calcification. 
Lipids and lipoproteins are considered important in the process of vascular 
calcification .  Calcium and cholesterol crystals appear to co-localize within the lipid core 
(112), and oxidized lipids have been shown to induce osteoblastic differentiation and 
calcification of calcifying vascular cells (149). This theory is further supported by studies 
which demonstrated spontaneous lipid accumulation within multicellular nodules prior to 
calcification, and stimulation of calcification in cultures of human vascular smooth muscle 
cells after addition of modified lipoproteins (150).  
Calcification of the intima is thus the net result of a balance of these and many other 
factors, promoting and inhibiting calcification. Histopathological studies have demonstrated 
presence of calcified nodules containing calcium hydroxyapatite within atherosclerotic 
plaque in the form of microscopic deposits, as early as type III or IV lesions, the “early 
atherosclerotic lesions”.  Calcification begins as small microscopic deposits within type III or 
IV lesions which coalesce to form large macroscopically detectable deposits as disease 
advances (152). 
 
1.4.2 Implications of plaque calcification 
 
While the initiation and progress of coronary artery calcification is multifactorial, it is 
essentially linked with the process of atherosclerosis, studies have demonstrated that it exists 
only in arteries with an active atherosclerosis process and is absent in normal arteries (153).  
There is however lack of consensus regarding the role of calcium in the atherosclerotic 
plaque as to whether it denotes a plaque as stable or prone to rupture.  
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Studies which have used fluoroscopy to assess segments of the coronary tree with 
known plaques morphology,  have indicated a wide range of histological plaque types present 
at segments, showing a specific pattern of calcification (154). While plaque ruptures were 
seen frequently in areas with speckled calcification, fragmented calcification, there was no 
evidence of rupture seen in segments without calcification. Healed or old ruptures were seen 
in areas of calcification, majority of the times associated with diffusely calcified areas (154).  
Thus there are two interpretations of coronary artery calcification: First, at the 
individual lesion level, calcification increases with progression of the plaque, often at later 
stages i.e. IV or V. During these initial stages of calcification there might be increased stress 
near the junction of the cap and the adjacent intima. It is here, at the interface between a high 
and low density tissue i.e. calcified and non-calcified atherosclerotic section, that plaque 
rupture often occurs. Thus during early stages of plaque disease, with moderate (specked, 
fragmented) calcification, it might make the plaque more prone to rupture, given that the 
plaque itself is vulnerable. 
As the degree of calcification increases, the number of interfaces between rigid and 
distensible plaque initially would increase until the point at which the rigid plaques coalesce. 
Calcification beyond this point may be associated with decreasing risk of plaque rupture, 
whereas the early or intermediate stages of calcification may actually enhance plaque 
vulnerability, by creating more junctions. 
A second interpretation could be at the level of the entire coronary tree i.e. for the 
patient rather than a single lesion. Thus, a heavily/ diffusely calcified plaque itself might not 
be prone to rupture, as supported by the stiffness and resistance to rupture demonstrated by 
plaques with extensively calcified plaques, compared with cellular lesions or normal vessel 
walls (155).  However, as it is a late feature in the cascade of atherosclerotic plaque 
formation, its presence implies the presence of early lesions elsewhere in the coronary tree. 
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The potential lipid-rich and possibly unstable plaques “the thin cap fibroatheromas”,  with 
lower amounts of detectable calcification. 
Thus while the role of calcification within the plaque is not yet completely 
understood, in the absence of available technology that allows easy visualization of the 
vulnerable plaque thus limiting ability to assess the risk of rupture at the level of an 
individual lesion, coronary artery calcium scores are useful for detection of individuals at 




1.5 Coronary artery calcification imaging 
 
 Coronary artery calcification can be detected by various modalities including 
fluoroscopy, CT, Xray, IVUS among others. Conventional fluoroscopy was the first 
technique for imaging coronary artery calcification (129), followed by digital subtraction 
fluoroscopy. Due to the poor spatial resolution, this technique was unable to detect small 
plaques and was taken over by high resolution EBCT, with its superior temporal and spatial 
resolution (157).   
The guiding principle of CT scanners is the differential attenuation of X-rays passing 
through various tissues of the body. EBCT scanners do not have the disadvantage of having a 
mechanically rotating gantry, unlike conventional CT scanners. An electron gun shoots the 
electrons that are then guided electro-magnetically to Tungsten target rings. The X-rays thus 
produced then pass through the patient and are detected on two parallel rings housed within 
the gantry of the scanner. It takes 100 milli-seconds (ms) for one sweep of the target rings. 
Considering that it requires 30-40 slices for an average 3 mm (range 1.5 – 6 mm) thickness to 
image the entire coronary tree, the entire heart can be imaged in 30 – 40 seconds. The 
radiation burden and motion artefacts are reduced by prospective gating, whereby the image 
acquisition is triggered at 60% - 80% of the RR interval on the ECG, corresponding to the 
end of diastole. The total radiation delivered during one study is approximately 0.8 – 1.3 
mSv. 
The main disadvantage of using conventional CT i.e. multi-slice CT,  rather than 
EBCT scanners was the use of a mechanically rotating gantry, and thus problems with 
movement and acceleration, necessitating much longer radiation exposure and poor temporal 
resolution. The gantry speed has improved through successive scanner generations and the 
current state of the art scanners can complete one rotation in 330 milli- seconds. However, 
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they are still limited and any further improvement is unlikely due to problems in handling the 
huge gravitational force generated by the rapid movement of a relatively heavy gantry.  
A few studies have compared the data variability between these two imaging 
modalities (EBCT and MSCT scanners) and they show good correlation between the scanners 
in terms of accuracy and reproducibility. Knez et al showed an excellent correlation between 
MSCT and EBCT for quantification of coronary calcium in 99 patients (r = 0.994, p = 
0.01)(158). Becker et al compared the two modalities in 100 patients and found a good 
correlation between the two types of scanners (159).
 
However, for the purpose of this study an EBCT scanner as used by Agatston et al, 
was used for all patients.  
 
1.5.1 Algorithms for Quantification of Coronary Calcium 
 
The calcium scoring system was first described by Agatston et al in 1990 (157). They 
described a scoring algorithm, which takes into consideration the area and density of the 
calcified plaque. Calcified foci within the outline of epicardial coronary arteries with a 
threshold area of 1 mm
2 
and a threshold attenuation value of 130 Hounsfield units are scored. 
CAC score is calculated as Maximal Computed Tomographic Number (MCTN) multiplied by 
area of calcification in mm
2
. The MCTN is obtained from the maximal Hounsfield intensity 
within the area of interest. For example, if the peak X-ray density of a calcified lesion is 400 
Hounsfield Units and the total area occupied is 10 mm
2
, then the CAC score using this 
method is: 4*10 = 40 Agatston units (Au). The score for each lesion in a given patient is 




While several other methods of calculating calcium mass such as volume based calcium 
quantification was proposed by by Callister et al (160) and calculation of total calcium mass 
of as a product of lesion volume, average CT density of the lesion in Hounsfield units and a 
calibration factor  (161). 
However, there is no standardised reference database for the mass and volume scores 
as yet. Further, majority of the existing studies have used the Agatston score in relation to 
coronary artery calcification. Thus, it continues to be the clinical standard used in majority of 
the centres  
 
1.5.2 Prognostic value of coronary artery calcification imaging 
 
Coronary artery calcification provides us a non- invasive anatomic assessment of the 
coronary tree. Presence of calcium within coronary arteries is pathognomic of plaque (153) 
and portents extensive atherosclerotic disease with the amount/extent of calcification closely 
related to total atherosclerotic plaque burden (144,153), and severity of coronary disease. It is 
a strong predictor of coronary events and all cause mortality in subjects with and without 
known coronary disease.  
The risk of coronary event and mortality rises with the presence of calcification (> 0 
Agatston units); with worsening prognosis as the amount of calcification increases, i.e. with 
increasing burden of calcification (>100 Agatston units and > 400 Agatston units) (134,162). 
Coronary artery calcification adds independent prognostic value to that offered by 
conventional risk factors alone (134,163,164), supporting its role as an important risk 
stratification tool. More recently, a report of American College of Cardiology Foundation 
Clinical Expert Consensus Task Force (165) regarding the risk assessment for CHD in 
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asymptomatic adults has also supported the independent prognostic ability of coronary artery 
calcification for CHD outcomes, beyond traditional risk factors.  
Several large scale studies in the last few years have evaluated the role of coronary 
artery calcification in different ethnic populations (134,166). While the prevalence of 
coronary calcification is significantly higher in subjects with traditional cardiovascular risk 
factors such as hypertension, diabetes, obesity, infrequent exercise, previous smoking, and 
hypercholesterolemia (148,166-169), the presence and burden of calcification differs among 
different groups (166,170,171). This difference is most striking among African American 
participants, who have been shown to demonstrate lower levels of calcification, despite 
demonstrating worse cardiovascular risk profiles, compared with North American Caucasian 
populations (166,170,172). However, recent prospective studies suggest similar mortality 
among different ethnic groups, for a given level of calcification (134,164) supporting its role 
as a risk stratification tool.  
When compared to the vast amount of data evaluating coronary calcification among 
Caucasians, there is little data regarding prevalence and extent of coronary artery 
calcification in South Asians. Till date, only two studies have evaluated the prevalence of 
coronary artery calcification among South Asians. They both involved a small number of 
subjects, and demonstrated conflicting results. The first study was by Hatwalkar et al (173) 
with a cohort of 156 South Asian subjects. They demonstrated a similar prevalence of 
coronary artery calcification between younger South Asians and North American caucasian, 
but a higher prevalence and extent of calcification when compared to Hispanics, African 
Americans and Asians. Furthermore, the higher prevalence of demonstrated a higher 
prevalence of coronary artery calcification in South Asians in the older age groups. 
Interestingly, this study had lower rate of smoking among Caucasians, with lower rates of 
hypertension and diabetes among South Asians than seen in most other studies.  
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The second study was performed by Chaturvedi et al, with 83 South Asian subjects 
(174), consisting a mix of subjects with known CHD as well as asymptomatic subjects. While 
the risk factor prevalence was similar to that seen in the general population, it demonstrated 
similar coronary artery calcification among South Asians and European. While the studies 
have provided us with comparative data, both these studies have been small and inadequately 
powered to assess ethnic differences in coronary calcification. 
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The basis for myocardial perfusion imaging is the visualization of myocardial blood 
flow. In normal coronary circulation, the blood flow through coronary epicardial arteries is 
autoregulated by the arterial bed in order to maintain tissue perfusion. When a stenosis 
develops, the pressure across the lesion drops and consequently, the arteriolar bed 
progressively dilates to maintain normal blood flow to the myocardium. However, this 
compensatory dilatation fails to cope with increasing severity of stenosis, beyond a certain 
point. These autoregulatory and vasodilatory reserves are thought to reach a maximum when 
a stenosis beyond 90% of the coronary artery diameter is present (175).  As the severity 
increases beyond this point the artery can no longer dilate to maintain normal perfusion flow 
and pressure, resulting in decreased myocardial blood flow during rest.  
However, during stress or hyperaemia, this disparity of blood flow between a normal 
and a stenosed artery is apparent at a much lower grade of coronary artery stenosis, starting at 
approximately 45% diameter stenosis and progressively worsening with increasing severity 
of stenosis (176). Thus a normal artery will dilate to a much greater extent than a stenosed 
one, causing increased blood flows. The resulting differential uptake, between areas supplied 
by normal and stenosed epicardial arteries forms the basis for myocardial perfusion imaging 
(177).  
The stress can be achieved through physiological means or pharmacological means 
i.e. through exercise using a treadmill or bicycle or through or pharmacological means i.e. 
using either vasodilators such as adenosine or dipyridamole or inotropes such as dobutamine.  
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The myocardial blood flow is visualized through use of radioactive tracers such as 
Thallium -201, 99m Technetium Sestamibi or 99m Technetium Tetrofosmin which are 
extracted up by the myocardium and the resulting gamma rays captured by the gamma 
camera. The resulting differential uptake of radioactive tracer secondary to regional 
myocardial flow disparities, downstream of coronary arteries with significant obstructive 
coronary artery disease during stress produces myocardial perfusion defects or “silent 
myocardial ischemia”. 
 
1.6.2 Perfusion imaging 
 
Myocardial perfusion imaging relies on the technique of single photon emission 
computed tomography (SPECT). The patient is injected with a radioactive isotope during 
stress, followed by image acquisition; and then separately undergoes “rest” or 
“redistribution”  injection and image acquisition. The isotope enters viable myocardial cells 
and emits gamma or X-rays. A gamma camera on a moving gantry rotates around the patient, 
and detects light created when the gamma rays collide with the sodium iodide crystals in 
front of the camera.  The machine software is programmed to know where camera head is in 
space and therefore can orient the heart in space. The images are then consolidated to produce 
a three-dimensional model of the source of activity by either filtered back projection or 
iterative methods. This model can then be viewed from any angle, or sliced in any plane for 
ease of interpretation.  
Myocardial perfusion scans represent global LV perfusion; therefore the size, severity 
and reversibility of the perfusion defect imply the total ischemic burden. Similarly a 
calculation of the number of segments involved on a multislice tomographic evaluation of the 
SPECT study can be used to calculate both the extent and severity of the ischemic 
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myocardium. Using sequential short axis slices a “polar map” can be either visually or 
quantitatively evaluated to provide the “total ischemic burden”. Short axis slices are used to 
evaluate the uptake in four broad quadrants (anterior, septal, inferior and lateral). The LV is 
further divided into apical, mid and basal segments; the apex is assessed with the vertical 
long axis slice. The slices are divided into 17-20 segments. The uptake is scored in 5 
grades(0, normal; 1, equivocal; 2, moderate; 3, severe reduction of radioisotope uptake; and 
4, apparent absence of tracer uptake). 
A representative method of scoring the total ischemic burden (178) is using summed 
stress, rest, and difference scores (SSS, SRS, and SDS). SSS and SRS determined by the sum 
of scores of each segment from the stress and rest images, respectively while summed 
difference scores (SDS) are determined by the sum of the difference between the SSS and the 
SRS.  The SDS can then be converted to percent myocardium ischemia by dividing the SDS 
by 68—the maximum potential score (4 X 17)—and multiplying by 100(179). While as SSS 
> 4 is considered suggestive of presence of myocardial ischemia (180), the percentage 
myocardium signifies severity of ischemia (181).  
 
1.6.2 Clinical correlation  
 
Myocardial perfusion imaging is a well validated technique for the non-invasive 
diagnosis of coronary artery disease (90, 91). Presence of ischemia on myocardial perfusion 
scintigraphy is strongly associated with adverse cardiovascular events even in the absence of 
ischemic symptoms, while absence of ischemia on perfusion imaging predicts a low risk of 
cardiovascular events (182). Numerous studies using this technique have been performed 
among subjects with known coronary disease, and have demonstrated independent prognostic 
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value of total ischemic burden in predicting adverse clinical outcome independent of severity of 
coronary disease and concomitant risk factors (136-138). 
More recently, the importance of flow limiting coronary disease as quantified by 
myocardial perfusion imaging have been assessed among asymptomatic populations including  
asymptomatic diabetics (139,183), those with intermediate Framingham risk scores (139) , as 
well in subjects with high coronary artery calcium scores (141,142). These studies have 
demonstrated a greater mortality in subjects with higher levels of silent ischemia, with absence 
of inducible ischemia has been shown to identify subjects with very low (<1% per year) risk of 
coronary events (143). 
Previous studies have also demonstrated an increasing prevalence of stress-induced 
ischemia detected by MPS with increase in CAC, among patients suspected to have CHD 
(179,184) as well as asymptomatic healthy subjects (140,185). However, while a high 
prevalence of silent myocardial ischemia is observed amongst subjects with CAC scores of 
more than 100 Agatston units, a negligible ischemia is demonstrated among subjects with 
low/ absent coronary calcium as demonstrated by our group and others (140,179,184,186).  
Thus, MPS is often used in conjunction with CAC imaging; with CAC providing a 
screening test for detecting presence of atherosclerotic coronary artery disease and MPS 
providing a functional assessment of flow limitation due to significant obstructive coronary 
artery disease.  
While there are ethnic differences in atherosclerotic burden as quantified by coronary 
artery calcification and related mortality, there is little data assessing ethnic difference in 
myocardial perfusion. Shaw et al (187), in a study carried out among African-American and 
North American caucasian populations, demonstrated a higher prevalence of moderate to 
severe myocardial perfusion defects among African-American compared with North 
American Caucasian. However, follow up from the study identified a greater risk of events 
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among African- Americans for all grades of perfusion abnormalities as compared with North 
American Caucasian, both before and after adjustment for cardiovascular risk factors. 
However, there appears to be no data regarding prevalence of myocardial ischemia in relation 
to coronary artery calcification among South Asians.  
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1.7  Hypotheses 
 South Asians have a higher prevalence of CHD and a higher mortality 
attributable to CHD. The reasons for this excess are not fully known. The currently known 
risk factors and risk stratification equations do not accurately assess the CHD risk in this 
population. Thus, we have an ethnic population which forms a quarter of the global population, 
with one of the highest CHD rates globally, both increasing at an exponential rate (2).  Despite 
the need for aggressive risk assessment and management in South Asians (188), there is a lack 
of accurate and robust risk stratification tools.  
Coronary artery calcification imaging and myocardial perfusion scintigraphy are well 
validated techniques for the non-invasive diagnosis of coronary artery disease. While 
coronary calcium scores correlate strongly with the total atherosclerotic plaque burden and 
elevated coronary artery calcification portents advanced atherosclerotic plaque, MPS detects 
presence of a hemodynamically significant flow-limiting coronary stenosis. The combination 
of these two tests thus provides a comprehensive assessment of the coronary arterial system. 
It is especially useful when studying the early stages of atherosclerotic disease i.e. before it 
becomes clinically manifest. Along with this there is a growing body of evidence to 
substantiate the role of inflammation in atherosclerosis initiation and progression. This has 
been measured through a variety of modality from intravascular imaging, plaque imaging to 
assessment of systemic inflammation using molecules such as CRP.  
However, majority of the studies using such techniques have been performed in 
predominantly European populations with little data available for South Asians.  
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We therefore carried out our study to test the following hypotheses: 
 
1. Do traditional risk factors correlate with markers of subclinical atherosclerosis among 
South Asians? 
2. Is there is higher prevalence of coronary artery calcification among in South Asians 
compared with Europeans? 
3. Is there is elevated risk of silent myocardial ischemia in South Asians compared with 
Europeans? 
4. Is there a greater degree of inflammation among South Asians compared with Europeans? 
















Figure 1.3 Presence of calcium in atherosclerotic plaque on histopathological and X-Ray 
examination of sections of the coronary tree.  








I conducted tests to compare measures of subclinical atherosclerosis, and their 
relationship to cardiovascular risk factors in 2369 UK South Asians and Europeans.  
Written protocols were prepared for all studies. Each study and accompanying 
protocol was reviewed, and approved, by the Local Research Ethic committee. All subjects 
gave written informed consent to participate in the research projects. This chapter describes 
the methods used for recruitment and characterisation of subjects, tests performed, and the 
approach to storage and analysis of data. 
 
2.2     Recruitment 
 
2.2.1 ‘LOLIPOP’ study 
 
 Participants were recruited as part of the London Life Sciences Prospective 
Population (LOLIPOP) Study. (PI’s Prof J S Kooner and Dr J C Chambers).  The LOLIPOP 
Study (illustrated in Figure 5.1) is a population-based investigation of cardiovascular risk 
among all South Asians and Europeans recruited through the age-sex lists of 58 General 
Practitioners (GPs) in West London, coordinated through the Cardiology Department at 
Ealing Hospital (Figure 2.1).  It is funded by the NHS R & D, GSK and Pfizer UK.  To date, 
30,000 men and women aged 35-75 have been recruited in the LOLIPOP cohort.  All patients 
of the collaborating GP surgeries, between the ages of 35-75, of all ethnicities and either sex, 
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were invited for a cardiovascular risk prevention assessment at their GP surgeries by trained 
research nurses.   
Clinical data were collected by the nurses according to a standard protocol, with 
regular data checking and quality control. The clinical assessments of the LOLIPOP study are 
detailed below (Section 2.5). The map shown in Figure 2.2 illustrates the three boroughs in 
West London from which the participants were selected (the areas are highlighted in red).  
 
2.2.2 LOLIPOP Intensively phenotyped cohort (IPC) sub-study 
 
 All eligible participants between the ages of 35-75 were randomly selected from the 
LOLIPOP study, by automated software and, stratified by age and ethnicity/ ancestry (South 
Asian [people with all four grandparents of South Asian origin] and European [people with 
all four grandparents of European origin] only).  This specification was designed to ensure, as 
far as possible, groups of homogeneous ancestry.  
Exclusion criteria included known cardiovascular disease, serious organ disease, 
systemic illness, serious psychiatric illness, and the presence of pathological Q waves on the 
ECG.  
2.2.2.1 Coronary artery calcification study 
 7056 potential participants were identified and contacted by invitation letter, 
and asked to attend two different London hospitals (Ealing and wellington Hospitals) for a 
range of cardiovascular tests. Out of those invited, 2600 (36.6%) subjects responded, and 
2369 (90%) responders consented to undergo CAC imaging. Discussions with some non-
participants revealed that most were deterred by the two separate hospital visits because of 
work commitments, while in a minority; anxiety about unknown hospital tests was the 
reason.  The characteristics of responders and non responders are given in Table 2.1. There 
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were some significant differences between the two groups, the responders were more likely to 
be male, were more healthy in terms of physical activity, smoking, waist/hip ratio, BMI, 
blood pressure and cholesterol, and they were more likely to have a family history of heart 
disease.  This seems to indicate that people with a stronger concern for health, with a better 
understanding of heart disease and implications due to a family history were more likely to be 
interested in, and respond to an invitation for a cardiovascular screening programme. There 
was no significant difference in response rates between South Asians and Europeans.  
The LOLIPOP- IPC sample consisted of 1356 South Asians and 1013 Europeans aged 
between 35-75 years (54.7 ±10.5), 35% female and none had documented CHD. Of the South 
Asian sample, 52.4% were Sikhs, 15.5% were Muslims, 25.6% were Hindus and 3.2% were 
Christians.  The large majority (95.6%) had been born outside the UK, with average UK stay 
of 29.8 ±18.4 years. 
Once volunteers responded with appropriate dates, an appointment letter was sent out 
for Ealing Hospital.  On arrival at Ealing Hospital for the first of their two appointments, the 
study protocol was explained to the participants and written consent was obtained. During 
this period, the inclusion criteria were reiterated to the participant; they confirmed that all 
four of their grandparents were either all Europeans or all South Asian (originated from the 
India, Pakistan, Bangladesh or Sri Lanka) 
 
2.2.2.2 Myocardial perfusion imaging study  
           Out of the 2369 subjects who consented to undergo coronary artery 
calcification was measured for all participants using electron beam computed tomography. 
Previous work by our group and others has demonstrated negligible prevalence of silent 
myocardial ischemia among subjects with coronary artery calcification of less than 100 
Agatston units (140,179,184). Thus, in order to minimise the number of subjects exposed to 
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radiation, a cut-off value of 100 Agatston units was used to select participants for myocardial 
perfusion imaging. 518 patients had CAC > 100 Agatston units and were invited for 
myocardial perfusion imaging. Of these, 256 (49%) participants consented to undergo 
myocardial perfusion imagining.  
 
2.3 Clinical measures  
 During the cardiovascular risk assessments, clinical information was collected by 
study nurses at the GP surgeries and corroborated by clinical notes (Table 2.2 a&b).  Nurses 
collected information about medical and family history, current prescribed medication, and 
smoking history.  Smoking was defined as never, former smoker or current smoker along 
with no of cigarettes per day in order to calculate pack years. Country of birth of participants, 
parents, and grandparents were also recorded, together with language and religion for 
assignment of ethnic subgroups.  A fasting blood sample was drawn to measure glycosylated 
haemoglobin (HbA1c) and lipid profiles. Physical assessments included anthropometric 
measurements, blood pressure, and 12 lead ECG.   
Height was measured using a stadiometer, mounted on a hard, flat surface.  Patients 
were measured without shoes, standing with their back to the height rule, both feet together, 
and with head, buttocks and heels touching the wall. Patients were asked to look directly 
ahead, and the stadiometer bar moved down to touch the top of the head, pressing the hair 
flat. For patients with turbans, the turban was removed. Height was recorded to the nearest 
0.1cm. 
Weight and body fat percentage were recorded using digital Tanita® scales. The 
scales were mounted on a hard, flat surface. The patient was weighed after an overnight fast, 
wearing light clothing only without shoes or socks. Weight was recorded to the nearest 0.1kg. 
The fat percentage is calculated using bioelectrical impedance analysis. A small amount of 
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electric current is passed through the body and the resistance that it encounters while passing 
through different tissues is calculated. The basic premise is that tissue resistance differs with 
lean tissue and muscle offering lower resistance to the tissues, compared to fat. 
Waist-hip ratio was measured after an overnight fast, with the patient undressed 
except for underwear, and standing erect, with feet together. Waist was defined as the point 
midway between iliac crest and lowest rib, identified by palpation, and waist circumference 
measured as the minimum circumference at this level. Hip circumference was defined as the 
maximum circumference over the greater trochanters and buttocks. Measurements were made 
using a non-stretchable measuring tape, applied around the body without twists, and gently 
touching skin, without compressing soft tissue. All measurements were recorded in 
centimetres, to the nearest 0.1cm. 
BMI was calculated by dividing the participant’s weight in kilograms by the square of 
his/her height in meters (BMI = kg / m
2
).  Waist-hip ratio (WHR) was calculated by dividing 
waist by hip measurements.  The metabolic syndrome was defined using the NCEP ATPIII 
criteria (Expert Panel of NCEP) and the new International Diabetes Federation criteria (2006)  
Hypertension was defined as history of hypertension or current use of 
antihypertensive medications 
 
2.4.0 Imaging  
 
2.4.1 Coronary artery calcification Imaging 
 
 Coronary artery calcification imaging was performed at the Cardiac Imaging and 
Research Centre (Wellington Hospital, UK), using a modified GE Imatron C-150 (San 
Francisco, CA, USA) electron beam computed tomography scanner equipped with high-
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resolution detectors (Figure 2.3). Coronary visualization was performed without contrast. In 
order to include the entire coronary tree, forty contiguous 3-mm slices were obtained during a 
single breath-hold, starting at the carina and proceeding to the level of the diaphragm. Scan 
time was 100-ms per slice, synchronized to 40% of the R-R interval (189). This gating 
algorithm minimizes motion artefact and results in excellent inter-scan reliability. All areas of 
calcification within the borders of a coronary artery with an optical density above 130 
Hounsfield units and an area greater than 1 mm
2
 were computed. Coronary artery 
calcification scores were calculated on an Aquarius workstation (TeraRecon, Inc., San Mateo, 
USA). Calcium scores between participants were adjusted with a standard calcium phantom.  
The output from EBCT scans was quantified into Agatston scores as described by Agatston et 
al(157).   
 In order to reduce inter-observer variability, image analysis was carried by only two 
research fellows trained in analysis of coronary artery calcification imaging at the same 
centre. For the purpose of the study, they were both blinded to the clinical and ethnic data. 
Midway through the study, 50 coronary artery calcification scans reported by one observer 
were reanalysed by the second observer and resulting coronary artery calcification scores 
compared to the original scores, in order to reassess and ensure low inter observer variability. 
There was excellent inter observer correlation with the original correlation coefficient for 
Agatston score between readers equal to 0.99 and the coefficient of variation equalling 2%.  
  Figures 2.4 and 2.5 show examples of EBCT scans performed in two people with 
very different levels of calcification.  Figure 2.4 shows a CT of the chest with a healthy heart 
and no coronary calcification and Figure 2.5 shows a heart with calcification of the left main 





2.4.2 Myocardial Perfusion Imaging 
 
Myocardial perfusion scintigraphy was performed using a 2-day protocol (stress and 
rest) with Technitium-99m sestamibi. Stress imaging was performed by use of  a symptom-
limited exercise treadmill test according to the Bruce protocol and pharmacologic stress using 
dipyridamole (190) or dobutamine (191) . Stress and rest SPECT images were acquired 60 to 
120 minutes after injection of 600 MBq Tc-99m sestamibi by use of a large field-of-view, 
dual-headed gamma camera equipped with a high-resolution collimator (SMV DSTi; GE 
Medical Systems, Buc Cedex, France).  Thirty-two projections (40 seconds per projection) 
were acquired over a 180° arc, from the 45° right anterior oblique position to the 45° left 
posterior oblique position. Strict quality control and motion artefact correction were used.  
Image Interpretation: Stress-rest Tc-99m sestamibi SPECT scans were interpreted by 
semi quantitative visual analysis, and the findings were categorized for overall interpretation 
as normal or abnormal. Semi quantitative visual analysis was performed by use of the 17-
segment model recommended by the American College of Cardiology/American Heart 
Association/American Society of Echocardiography/ American Society of Nuclear 
Cardiology (Figure 2.6 and 2.7). Tracer uptake was scored in each segment by use of a 5-
point scoring system (0, normal; 1, equivocal; 2, moderate; 3, severe reduction of 
radioisotope uptake; and 4, apparent absence of tracer uptake). Summed stress and rest scores 
were categorized as low (0-4), intermediate (5-8), or high (>8). Summed difference scores 
(SDS) were categorized as low (0-2), intermediate (3-7) or high (>7). Gated SPECT was used 
to define artefacts when required. An SSS >4 was considered to be abnormal. SDS was 
determined by the sum of the difference between the SSS and the SRS. The SDS was 
converted to percent myocardium ischemia by dividing the SDS by 68—the maximum 
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potential score (4 X 17)—and multiplying by 100.(179) The extent of reversible myocardial 
ischaemia was categorized as mild (<5%), moderate (>5 and ≤10%), or large (>10%). 
 
2.5 Statistical analysis 
 
 All analyses were performed using the statistics programme Statistical Package for 
the Social Sciences (SPSS) version 16.0 (Chicago, IL, USA). Categorical data are presented 
as number (percent), and continuous data as mean value± SD. The chi-square test was used to 
compare categorical variables while comparisons of continuous variables between two groups 
were performed using student t tests. All tests of significance were two-tailed, and 
significance was defined at the < 0.05 level.  
 
2.5.1 Coronary artery calcification 
 
  Due to the non-Gaussian nature of CAC and high prevalence of zero Agatston unit 
scores, CAC was classified into the following categories: 0 AU, 1-10 AU, 11-100 AU, 101-
400 AU and >400 AU respectively. Thus, for the purpose of analysis two end points were 
used, one using presence of CAC defined as Agatston score >0 Au; and the other using CAC 
as categorical variable and classified into the above mentioned categories, in order to assess 
extent of plaque burden.  
  Prevalence and extent of CAC were compared across ethnic groups. The relations 
between risk factors and CAC were analyzed, both before and after adjusting for concomitant 
risk factors, using regression models. While a binomial logistic regression model was used to 
evaluate associations between risk factors and the presence of CAC, a separate ordinal 
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regression model was used to assess the predictive ability of risk factors for the extent of 
CAC.  
 
2.5.2 Myocardial perfusion scintigraphy 
 
Prevalence and extent of myocardial ischemia was compared across ethnic groups. 
The relationships between risk factors and myocardial ischemia were analysed using 
regression models, both before and after adjusting for concomitant risk factors. While a 
binomial logistic regression model was used to evaluate associations between risk factors and 
the presence of MPS abnormalities, an ordered logistic regression analysis was applied to 
identify clinical predictors of severity of myocardial ischemia. The resultant estimates 




2.6 Power calculation 
 
Power to detect risk associations between traditional cardiovascular risk factors and 
the primary endpoint of coronary calcium was calculated for the baseline study for the whole 
cohort and by gender, using logistic regression for a cohort study design. Estimates of the 
base-line prevalence of coronary calcification were obtained through published literature. The 
prevalence of subclinical disease is expected to range from approximately 15 % in the 
youngest women to almost 100 % in the oldest participants, as seen in studies performed in 
Northern European and American Caucasian populations (168).  
 Power to detect ethnicity-specific differences in coronary calcification was 
considered by treating ethnicity as a risk factor with 50% prevalence. A separate power 
calculation was obtained to detect differences in the correlation coefficient between relevant 
risk factors and coronary calcification, for South Asians compared to Northern Europeans. 
The power calculations were performed for each gender, for detecting associations of risk 
factors with varying prevalence levels and prevalence of coronary calcium. (Table 2.4) 
 For men, for an alpha error of 5 percent, the study will have more than 90 percent 
power to identify relations between risk factors with a prevalence of at least 10 percent in the 
cohort and the presence of coronary calcium, with an odds ratio of 1.5 or greater. The power 




2.7 Data storage 
Data were stored in a purpose-built database written in Microsoft Access. The database had a 
modular design, with each component supporting specific areas of the research work. 
Database functions included selecting subjects for invitation, generating patient letters for 
invitations and appointments, collection and collation of patient data, importing biochemical 
results directly from the analytic laboratories, validation of data, maintaining data security 
and enabling data analysis. A data management committee was established that had 
responsibility for maintaining the database, supervising data security, validating and 
monitoring data collection for completeness, accuracy and timeliness. Data collection was 
validated in the following ways: range and logic checks during data entry, and systematic 
searches for incomplete datasets, duplicate patient attendances, extreme values, logical 
inconsistencies, digit preference, and systematic bias between observers. Once validated the 




Table 2.1 Characteristics of responders and non responders for LOLIPOP –IPC study  
 Responders  Non responders P value 
European (%) 44 44 0.35 
Male Gender (%) 65 57 <0.001 
Framingham score  0.09 0.12 <0.001 
Family history of CAD (%) 25 20 <0.001 
Ever Smoker (%) 44 56 <0.001 
    
Waist-Hip ratio 0.93(0.082) 0.94(0.084) 0.02 
Body mass index(Kg/M
2)
 27.3(4.4) 27.6(4.9) 0.008 
Body Fat (%) 30.9(8.5) 32.0(8.9) <0.001 
PAI 1.76(0.96) 1.65(0.98) <0.001 
    
Total Cholesterol (mmol/l) 5.4 5.45 0.083 
LDL Cholesterol (mmol/l) 3.5(0.8) 3.4(0.8) 0.1 
HDL Cholesterol (mmol/l) 1.3(0.34) 1.4(0.34) 0.5 
    
History of hypertension (%) 28% 27% 0.3 
Diastolic blood pressure (mm 
Hg) 
80.4(10.2) 81(10.8) 0.03 
Systolic blood pressure (mm 
Hg) 
132(18.9) 133(20.4) 0.003 
    
Diabetes mellitus (%) 15 15 0.9 
HbA1C (%) 6.9(1.5) 7.0(1.4) 0.3 











 Weight *  
 Body mass index *  
 Waist circumference *  
 Waist hip ratio *  
Haemodynamic factors Blood pressure Systolic BP * 
  Diastolic BP * 
Lipid profiles Total cholesterol *  
 Low density lipoprotein 
cholesterol * 
 
 High density lipoprotein 
cholesterol * 
 
 Total: HDL cholesterol ratio*  
 Triglycerides *  
Fasting glucose levels Fasting glucose *  
 HbA1c *  
Disorders Diabetes *  
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 Measures  
 Hypertension *  
 Metabolic syndrome NCEP ATPIII * 





Coronary artery calcification 
  Myocardial perfusion Imaging* 
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Table 2.2b:   
Age distribution of participants 








35-44 128 82 90 57 
45-54 276 204 162 72 
55-64 230 223 198 101 
65-75 200 198 76 72 




Table 2.3(a) risk factors among male participants 
 South Asians Men (834) Europeans Men(707) P value 
Age (Years)  55.5 ± 10.3 57.56 ±10.96 <0.001 
Framingham score 0.08 0.11 <0.001 
Physical activity index 1.51 2.14 <0.001 
    
Body mass index (Kg/M
2
) 26.7 27.63(4.34) <0.001 
Waist Hip ratio 0.96 ±0.06 0.94 ±0.07 <0.001 
Ever Smoker (%) 22% 57% <0.001 
    
Diabetes Mellitus (%) 17% 10% <0.001 
Glucose (mmol/L) 5.94 ± 1.91 5.48 ±1.41 <0.001 
HbA1C 6.07 ±1.21 5.45 ±0.83 <0.001 
    
Total Cholesterol (mmol/L) 5.28 ±1.05 5.55 ±1.04 <0.001 
LDL Cholesterol (mmol/L) 3.29 ±0.88 3.5 ±0.88 <0.001 
HDL Cholesterol (mmol/L) 1.2 ±1.27 1.33 ±0.33 <0.001 
Triglycerides (mmol/L) 1.7 ±1.4 1.62 ±1.16 0.16 
On Statins (%) 16% 7% < 0.001 
 
   
Hypertension (%) 53% 45% <0.001 
Systolic blood pressure (mmHg) 133 ± 17.26 135 ± 18 0.006 
Diastolic blood pressure (mmHg) 82.4 ± 10 82.58 ± 10.0 0.343 
    
Metabolic syndrome-IDF (%) 20 7 <0.001 
Metabolic syndrome- NCEP  (%) 26 20 0.02 
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Table 2.3 (b) risk factors in Women 
 South Asian Women 
(522) 
European Women (306) P value 
Age (Years) 54.3 ± 9 56.2  ±10 <0.001 
Framingham score 0.06 0.05 0.05 
Physical activity index 1.51 2 <0.001 
Body mass index (Kg/M
2
) 27.8 ± 4.9 26.8 ± 5.3 0.006 
Waist Hip ratio 0.8  ± 0.08 0.9 ± 0.08 <0.001 
Ever Smoker (%) 0.5 31 <0.001 
    
Diabetes Mellitus (%) 23% 7% <0.001 
Serum glucose (mmol/L) 5.8 ± 2 5.3 ± 1.6 0.14 
HbA1C (%) 6.1 ±  1.2 5.6  ± 1.0 <0.001 
    
Total Cholesterol (mmol/L) 5.4 ± 1.01 5.7 ± 1.0 <0.001 
LDL Cholesterol (mmol/L) 3.3  ±  0.8 3.5 ±  0.9 0.04 
HDL Cholesterol (mmol/L) 1.4 ±  0.3 1.6 ± 0.4 <0.001 
Triglycerides (mmol/L) 1.5  ±  0.7 1.3 ±  0.8 0.008 
On Statins (%) 14% 7% <0.001 
Hypertension (%) 39% 31% 0.03 
Systolic blood pressure 
(mmHg) 
125 ±  11 124 ±   11 0.258 
Diastolic blood pressure 
(mmHg) 
77 ±  10 76 ±  10 0.109 
Metabolic syndrome-IDF 
(%) 
16 10 0.007 
Metabolic syndrome- 
NCEP  (%) 
32 16 <0.001 
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Table 2.4 Power to Detect Cross-Sectional Risk Associations with Coronary Calcium  
 









(n = 2000; 
estimated baseline 
prevalence of 
coronary calcium = 
39%) 
Men only  
(n = 1000; 
estimated baseline 
prevalence of 
coronary calcium = 
43%) 
Women only  
(n = 1000; estimated 
baseline prevalence of 
coronary calcium = 25%) 
10% 1.5 77 49 44 
 2.0 > 95 83 87 
30% 1.5 > 95 >95 76 
 2.0 > 95 >95 >95 
50% 1.5 > 95 >95 83 




Figure 2.1:   Schematic representation of the LOLIPOP and LOLIPOP atherosclerosis 
studies 
Informed Consent  
Medical history 
Basic physical assessment 
Blood and urine tests 
 
LOLIPOP Atherosclerosis Study  
(n = 2369) 
London Life Sciences Prospective Population (LOLIPOP) 
Cohort Study  




18,000 South Asians, 
35-75 yrs 
Myocardial Perfusion 
Imaging in subjects 
with CAC >100 AU 
Coronary artery 
Calcification using 
Electron Beam CT  
75 
 

































Chapter 3:  Prevalence of Coronary Artery Calcium among asymptomatic South 
Asians and Europeans  
 
3.1 Abstract 
Background: Coronary heart disease mortality is 70% higher amongst UK South Asian 
compared with Europeans. Current risk stratification tools and biomarkers do not allow 
accurate identification of South Asians at increased risk of coronary heart disease. Coronary 
artery calcification is highly correlated with coronary plaque burden, and is an independent 
predictor for future coronary heart disease events in North American and Europeans 
populations. We hypothesised that coronary artery calcification is increased in South Asians 
compared with Europeans, and may provide a non -invasive tool for assessment of increased 
coronary heart disease risk in South Asians. 
 
Methods:  Using electron beam computed tomography; we assessed coronary artery 
calcification among 2369 asymptomatic South Asians and Europeans men and women, aged 
35 to 75 years, part of the London Life Sciences Population (LOLIPOP) study. 
   
Results: Coronary artery calcification was more common in men than women, and coronary 
artery calcification scores were closely associated with age, cigarette smoking, hypertension, 
systolic blood pressure, diabetes, total cholesterol and metabolic syndrome. In contrast, there 
were no differences in either coronary artery calcification prevalence or mean levels of 
coronary artery calcification between South Asians and Europeans, after adjustment for the 




Conclusions: Coronary artery calcification is not increased in South Asians compared with 
Europeans, in any age group or in either gender. This contrasts with the almost 2-fold higher 
risk of myocardial infarction and coronary heart disease mortality observed in South Asians. 
Further research is needed to assess the mechanism of aggressive coronary artery disease, and 




South Asians (people originating from India, Pakistan, Bangladesh and SriLanka) 
account for almost a quarter of the global coronary heart disease (CHD) deaths (1). In the 
UK, South Asians form the largest ethnic minority group with a two-fold higher coronary 
heart disease mortality rate compared with the general population (4).  
Global registries such as INTERHEART (5) suggest an important role for traditional 
risk factors in CHD in all ethnic groups. However, such factors (8,47,192) and risk scores 
using these factors, such as the Framingham function do not predict the higher CHD 
mortality in South Asians (109). Therefore, accurate and robust risk stratification is lacking 
for South Asians. 
Intimal calcification occurs within coronary arteries in the presence of atherosclerotic 
plaque, and is closely correlated with histomorphometric plaque burden (r > 0.90)(130) and 
severity of coronary disease (144,153,193). Coronary artery calcification (CAC) as detected 
by Electron Beam Computerized Tomography (EBCT) is a strong predictor of coronary 
events and all cause mortality in subjects with and without known coronary disease. It also 
adds independent prognostic value to that offered by conventional risk factors alone 
(134,164,194), supporting its role as a robust risk stratification tool. However, the majority of 
this data is from North American and Europeans populations, with little data existing in 
South Asians. The purpose of the present study was to test the hypothesis that CAC is 
elevated in South Asians compared with Europeans, and predicts the increased CHD risk in 




3.3 Methods:  
I conducted coronary artery calcium imaging on 2369 subjects recruited from the 
LOLIOP study. While the methods for the study are described in detail in the methods and 
materials chapter. A brief overview follows.  
Subjects: 834 male and 522 female South Asians, and 707 male and 306 female 
European participants between the ages of 35-75, and no history of clinical CHD underwent 
coronary artery calcium imaging. Exclusion criteria were history of known CVD, systemic 
illness, serious psychiatric illness, presence of pathological Q waves on the ECG. All 
participants provided informed written consent. The LOLIPOP study is approved by the 
Ealing and St Mary’s Hospitals Research Ethics Committees. 
 Measurements: An interviewer-administered questionnaire was used to collect 
data on medical history, family history, current prescribed medication (verified from the 
practice computerised records), and cardiovascular risk factors. Physical assessment included 
anthropometric measurements (height, weight, waist, hip) and blood pressure. For the 
purpose of this study, hypertension was defined as history of hypertension, a systolic pressure 
>140mm Hg, or a diastolic pressure  >90 mm Hg and diabetes defined as history of diabetes 
mellitus or a fasting glucose > 7mmol/l.(195)  
Imaging: CAC imaging was performed at the Cardiac Imaging and Research 
Centre (Wellington Hospital, UK), using a modified GE Imatron C-150 (San Francisco, CA, 
USA) EBCT scanner equipped with high-resolution detectors. Coronary visualization was 
performed without contrast, with a scan time of 100-ms per slice, synchronized to 40% of the 
R-R interval(189). Coronary artery calcification scores were calculated on an Aquarius 
workstation (TeraRecon, Inc., San Mateo, USA). Calcium scores between participants were 
adjusted with a standard calcium phantom.   
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The output from EBCT scans was quantified into Agatston scores as described by 
Agatston et al(157).  Due to the non-Gaussian nature of CAC and high prevalence of zero 
Agatston unit scores, CAC was classified into the following categories: 0 AU, 1-10 AU, 11-
100 AU, 101-400 AU and >400 AU respectively.  
Thus, for the purpose of analysis two end points were used, one using presence of 
CAC defined as Agatston score >0 Au; and the other using CAC as categorical variable and 
classified into the above mentioned categories, in order to assess extent of plaque burden.  
 In order to reduce inter-observer variability, image analysis was carried by two 
research fellows trained in analysis of CAC imaging at the same centre. For the purpose of 
the study, they were both blinded to the clinical and ethnic data.  
 Statistics: All analyses were performed using the statistics programme Statistical 
Package for the Social Sciences (SPSS) version 16.0 (Chicago, IL, USA). Categorical data 
are presented as number (percent), and continuous data as mean value± SD. The chi-square 
test was used to compare categorical variables while comparisons of continuous variables 
between two groups were performed using student t tests. All tests of significance were two-
tailed, and significance was defined at the < 0.05 level.  
Prevalence and extent of CAC were compared across ethnic groups. The relations 
between risk factors and CAC were analyzed, both before and after adjusting for concomitant 
risk factors, using regression models. While a binomial logistic regression model was used to 
evaluate associations between risk factors and the presence of CAC, a separate ordinal 






Clinical and biochemical characteristics of patients 
South Asians were on average three years younger than Europeans, with a higher 
prevalence of diabetes mellitus, hypertension, and metabolic syndrome. South Asians also 
had higher serum glucose and triglycerides levels with lower total cholesterol, HDL and LDL 
cholesterols, physical activity index and smoking rates compared with Europeans. 15% of 
South Asians were on cholesterol lowering medications compared with 8% of Europeans 
(Table 3.1).  
 
Prevalence and extent of coronary artery calcification among UK South Asians and 
Europeans 
The age- and gender-related burden of CAC among South Asians and Europeans is 
shown in Figures 3.1 (CAC prevalence) and 3.2 (CAC extent). The prevalence and extent of 
CAC increased with age and were higher in men compared with women (p<0.001). While 
univariate analysis suggested a tendency towards lower prevalence and extent of coronary 
artery calcification among South Asians compared with Europeans (CAC prevalence, 
p=0.053; CAC extent, p =0.07), there were no significant differences among the two 
populations after adjusting for age and gender. Similar results were obtained when data were 
analysed using Agatston score of > 10 as threshold for presence of coronary artery 
calcification.   
Using thresholds of 100 AU and 400 AU, to assess for ethnic differences in moderate 
and extensive atherosclerotic plaque, suggested a lower prevalence of extensive plaque 
among South Asians compared with Europeans (Table 3.2). However, there were no 




Predictors of presence of coronary artery calcification 
A multivariable logistic regression model using cardiovascular risk factors and 
ethnicity explained about 37% of the variation in CAC in this population. An increase in age, 
statin use, male gender, hypertension, current smoking and diabetes were independently 
associated with CAC (Table 3.3). After adjustment for cardiovascular risk factors, ethnicity 
was not related to prevalence of CAC, OR=1.1 (95% CI 0.8, 1.3).  
Ethnic-specific analyses were performed to evaluate effect of differences in risk factor 
profiles on prevalence of CAC, within each ethnic group (Table 3.4). The regression model 
used had similar concurrent predictive ability for the two ethnic groups, explaining about 
38% of the variation in South Asians and 36% in Europeans. Age, BMI, and LDL, along with 
male gender, and use of cholesterol lowering medication were positively associated with 
presence of CAC among both South Asians and Europeans.  While prevalence of 
hypertension and diabetes were associated with presence of CAC in South Asians, an 
increase in triglycerides and current smoking were positively related to CAC presence in 
Europeans.  
 
Predictors of extent of coronary artery calcification 
A univariate ordinal regression demonstrated age, BMI, current and former smoking, 
statin usage, presence of hypertension or diabetes mellitus, male gender and Europeans 
ethnicity, as well as serum HDL and triglyceride levels were associated with elevated odds 
for the increasing extent of CAC. While unadjusted OR suggested higher CAC extent among 
Europeans, on adjusting for age and gender, using a multivariable ordinal regression model 
the ethnic differences no longer remained significant. Further analyses were performed 
adjusting for conventional cardiovascular risk factors and ethnicity, using a multivariable 
ordinal regression model. Age, male gender, current smoking, statin use, diabetes, 
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hypertension and LDL cholesterol were all positively associated with increase in extent of 
CAC (Table 3.5).   Ethnicity appeared not to influence CAC levels, with a relative difference 
of 1.05 (95% CI 0.9, 1.3), for South Asians compared with Europeans participants. 
Separate analyses were performed for each of the ethnic populations in order to 
evaluate group-specific relationships (Table 3.6). The multivariate models used to predict 
extent of CAC had similar concurrent predictive abilities for both ethnicities and explained 
38% of the variation in CAC prevalence. Increasing age, presence of diabetes, hypertension, 
male gender, statin usage and current smoking were associated with an increase in extent of 
CAC for both populations. While BMI and LDL showed significant associations amongst the 
South Asians participants; former smoking and triglycerides were significant risk factors for 
extent of CAC in Europeans. 
 
3.5 Discussion 
 In this cohort of asymptomatic men and women, aged 35-75 years, we found no 
ethnic group differences in either the prevalence or extent of CAC amongst South Asians and 
Europeans. CAC was similar in the two populations, both before and after adjustment for 
conventional cardiovascular risk factors. CAC did not predict or identify the excess CHD risk 
in South Asians in this sample.  
Consistent with existing data, we found that conventional cardiovascular risk factors 
were associated with both prevalence and extent of CAC (166,196). The prevalence and 
amount of CAC among Europeans in our study was lower than reported in similar studies 
using asymptomatic Caucasian populations, such as the Multi Ethnic Study of 
Atherosclerosis (MESA) trial (166). This could be explained by the younger age of 
participants in our study compared with the MESA sample. The age range in our study was 
selected to compare subclinical atherosclerosis in younger age groups because of the high 
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incidence of CHD found in young South Asians (10), compared with Europeans. Our data is 
consistent with study done by Chaturvedi et al (174) who demonstrated similar CAC among 
South Asians and Europeans with, and without known coronary artery disease, but contrasts 
with the study by  Hatwalkar et al (173) who demonstrated a similar prevalence of CAC 
between younger South Asians and North American Caucasian, but a higher prevalence in 
South Asians in the older age groups. Our study differs from the study conducted by 
Hatwalkar et al in that it is population-based, has a larger number of South Asians (300 
subjects compared with the 30 subjects) above the age of 60 years, a broader age range of 
participants and includes both genders. Our results, therefore, might reflect the population 
distribution of CAC more accurately. To our knowledge, ours is the largest study evaluating 
the distribution of CAC as a marker of atherosclerosis among asymptomatic South Asians 
and includes a population-based sample rather than physician referred subjects. Furthermore, 
we have assessed both presence and burden of plaque and have used stringent ethnic group 
classification and standardised assessment. This greatly increases the power of the study to 
accurately explore the differences in coronary artery calcification between South Asians and 
Europeans. 
 
Previous studies have documented ethnic group variation in distribution and 
prevalence of CAC. Several studies have demonstrated a lower prevalence and extent of CAC 
among AA participants, despite demonstrating worse cardiovascular risk profiles, compared 
with North American Caucasian populations (166,170,172). Histopathological evidence also 
suggests relatively lower levels of calcification within atherosclerotic plaques in African 
American (AA) populations (197). Several explanations have been put forward to explain 
these differences in CAC. Firstly, calcification within plaque is an active process, and is 
modulated by a variety of factors (148,198,199); there could therefore be an ethnicity-specific 
88 
 
difference in these factors (200), resulting in differing degrees of calcification within plaques 
across ethnic groups. Secondly, if differences in plaque composition are present, this may 
result in ethnic group differences in susceptibility of plaque to rupture. Thus, although worse 
cardiovascular risk profiles do not portent more extensive CAC, they might signify greater 
vulnerability of plaque and therefore a higher risk of coronary events (201) in AA compared 
with North American Caucasians. This argument is supported by studies which have 
demonstrated that similar extent of CAC does not have the same prognostic implications for 
all ethnic groups. Recent studies have demonstrated higher relative risk for cardiac events and 
higher coronary mortality (134,164,202) for AA populations compared with Europeans, 
despite lower prevalence and extent of CAC. Furthermore, studies using CT angiography 
have demonstrated a higher risk of acute coronary syndromes among subjects who exhibit 
plaques with evidence of positive remodelling and lower calcification burden, advancing this 
argument (203)   
  Our data do not show any differences in CAC between UK South Asians and 
Europeans, despite a worse cardiovascular risk profile among South Asians. This is in 
contrast to the excess CHD risk observed in South Asians, and has several important 
implications. Firstly, the plaque morphology and composition might vary between South 
Asians and Europeans. This could signify that either: a) There is an ethnicity-specific 
difference in the process of  calcification, resulting in differing degrees of calcification within 
plaques, thus a similar extent of calcification might signify varying amounts of total 
atherosclerotic plaque burden and thus differences in severity of coronary artery disease 
among South Asians and Europeans (204), or b) While the total atherosclerotic burden is the 
same in the two populations; there is greater vulnerability/ inflammation of plaque, with a 
higher propensity to rupture or undergo thrombosis in South Asians, compared with 
Europeans. This inflammation could be a result of either differences in plaque morphology 
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and composition or a higher degree of systemic inflammation or elevated levels of 
prothrombotic factors in South Asians, compared to Europeans, exposing them to a higher 
CHD risk 
Inflammation is one of the key factors in initiating atherosclerosis as well as  the 
pathogenesis of vulnerable plaques (49). This is supported by studies done in animal models 
as well as those among  human cases of sudden death, demonstrating increased macrophage 
activity in plaques which underwent rupture and subsequent thrombosis (51). Furthermore, 
recent studies in human subjects have shown markedly increased inflammation within active 
atherosclerotic plaques in carotid arteries (52,53). 
South Asians exhibit a high prevalence of diabetes, hypertension, abdominal obesity 
and metabolic syndrome, with lower HDL cholesterol levels (54-57). Presence of these risk 
factors is associated with greater inflammation (58,59). Furthermore, South Asians also 
demonstrate elevated levels of C-reactive protein (CRP) (60), from ages as low as 9-10 year 
(57). CRP is an important marker of inflammation, with elevated levels of CRP strongly 
associated with increased macrophage activity within plaques (63,64), and is considered an 
independent predictor of future cardiovascular events (51,65). Results from the recently 
published JUPITER trial further highlight the importance of inflammation by demonstrating 
substantial decreases in cardiovascular events in even low risk populations following 
reductions in CRP levels (205). Along with this, South Asians also demonstrate elevated 
levels of homocysteine (22), and small oxidized LDL (206), factors known to be associated 
with accelerated atherogenesis and increased thrombogenecity. Recent papers by our group 
have also demonstrated lower CAC values, with lower risk of CAC progression in subjects 
with high levels of autoantibodies against oxidised LDL (207), further marking the 
importance of biological factors in coronary artery disease. 
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 In addition to these biological factors, South Asians have also been shown to 
demonstrate high levels of psychosocial stress and chronic stress, compared with Europeans 
(91).  Psychosocial stress has been shown to further stimulates the activation of the 
sympathetic nervous system, cause endothelial dysfunction and release of proinflammatory 
cytokines and prothrombotic responses which in turn promote atherogenesis (88). 
Furthermore, stress has also been found to be correlated to CAC (99), and to silent 
myocardial ischaemia (100), as demonstrated by our group among others. This further lends 
strength to the argument that systemic factors have an important role in coronary artery 
disease. 
While these factors are known to be associated with accelerated atherogenesis and 
increased thrombogenecity, and their exact role in the excess CHD in Indian ascertained, they 
are likely to be contributory to increased vulnerability of atherosclerotic plaque in South 
Asians. 
 The increased CHD mortality in South Asians could, therefore, be a consequence of 
greater levels of vulnerability of the atherosclerotic plaque, as opposed to higher 




 In conclusion, I demonstrated similar prevalence and extent of CAC among South 
Asians and Europeans, this contrasts with 2-fold higher risk of myocardial infarction and 
CHD mortality observed in South Asians. Whether the elevated coronary artery disease 
mortality among South Asians reflects differences in plaque composition or an increased 
tendency of plaque to undergo rupture/ thrombosis, compared with Europeans, is yet to be 
ascertained.   
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Age (Years) 54 ±10 57± 10 <0.001 
Male Gender (%) 62 70 <0.001 
    
Physical Activity Index 1.5±0.8 2±1 <0.001 
Body Mass Index (kg/m
2
) 27±4 27±5 0.18 
    
Hypertension (%)  48 42 <0.001 
Systolic Blood Pressure (mmHg) 131 ± 19 132 ±19 0.03 
Diastolic Blood Pressure (mm Hg) 80±10 81±10 0.47 
    
Diabetes (%) 18 7 <0.001 
Serum Glucose (mmol/l) 5.8 ±1.9 5.4 ±1.4 <0.001 
    
Statin Usage (%) 15 8 <0.001 
Total Cholesterol (mmol/l) 5.3 ±1.1 5.6±1 <0.001 
LDL Cholesterol (mmol/l) 3.3 ±0.9 3.5+0.9 <0.001 
HDL Cholesterol (mmol/l) 1.2 ±0.3 1.4 ± 0.4 <0.001 
Triglycerides (mmol/l) 1.6 ±1.2 1.5 ±1.1 <0.001 
    
Current Smokers (%) 7 16 <0.001 
Former Smokers (%) 7 37 <0.001 
    
Metabolic Syndrome (IDF definition) 
(%) 
19 8 <0.001 









Table 3.2: Prevalence of Coronary Artery Calcium among South Asians and Europeans





Coronary artery calcification 
> 0 Au 
 
49 % 53 % 0.06 
Coronary artery calcification 
>100 Au 
 
21% 23 % 0.1 
Coronary artery calcification 
>400 Au 
 
8 % 10 % 0.07 
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 Table 3.3  Estimates of Change in Odds for prevalence of CAC > O AU 
 
Variable Odds Ratio 
(95%CI) 
P value 
   
Model 1
 Race (SA Vs E) 0.9 (0.7, 1.0) 0.06 
   
Model 2
   
Race (SA Vs E) 1.1 (0.9, 1.3) 0.3 
Age (10 years) 2.8 (2.5, 3.0) <0.001 








 2.56(2.3, 2.8) <0.001 
Diabetes 1.55 (1.1, 2.1) 0.008 
Hypertension 1.49 (1.2, 1.8) <0.001 
Smoker 1  
1.12 (0.83, 1.4) 0.49 
1.56 (1.1, 2.2) 0.014 
Body mass index (kg/m
2
) 1.07 (1.04, 1.09) <0.001 
Statin usage 2.3 (1.6, 3.1) <0.001 
   
   
Race (SA Vs E) 1.054(0.87, 1.3) 0.68 
Gender (Male Vs Female) 3.79 (2.9, 4.9) <0.001 
   
Triglycerides (mmol/l) 1.14 (0.98 , 1.3) 0.078 
HDL cholesterol (mmol/l)
 1.05 (0.74, 1.48) 0.77 
LDL cholesterol (mmol/l) 1.3 (1.1, 1.47) <0.001 
   
R
2 
for model 0.37  
 
Change in odds for presence of coronary artery calcification per unit increase in risk factor, 
using logistic regression  
 
Model 1: Unadjusted OR  
Model 2: Adjusted for age and gender 
Model 3: Adjusted for standard risk factors
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Change in odds for presence of coronary artery calcification, per unit increase in risk factor, adjusted for all variables listed, estimated using logistic 
regression 
 South Asians 
Odds Ratio (95%CI) 
P value Europeans 
Odds Ratio (95%CI) 
P value 
Age (10 years) 2.7 (2.3, 3.1) <0.001 2.4 (2.0, 2.8) <0.001 
Gender (Male Vs Female) 3.38 (2.8, 4.1) <0.001 3.43 (2.7, 4.2) <0.001 
Diabetes 1.76 (1.7, 2.5) 0.006 1.2 (0.6, 2.3) 0.60 
Hypertension 1.5 (1.1, 1.9) 0.003 1.45 (1.05, 2.02) 0.21 
Statin use 2.1 (1.4, 3.2) <0.001 2.9 (1.4, 5.8) 0.002 
     
Former smoker 0.82(0.4, 1.3) 0.46 1.26(0.9, 1.7) 0.168 
Current smoker 1.59 (0.89, 2.5) 0.12 1.4 (0.94, 2.23) 0.08 
     
Body mass index (kg/m
2
) 1.07 (1.03, 1.11) <0.001 1.05 (1.01, 1.09) 0.006 
HDL Cholesterol (mmol/l) 0.97 (0.6, 1.5) 0.88 1.16 (0.71, 1.9) 0.539 
LDL Cholesterol 
 
(mmol/l) 1.3 (1.1, 1,6) <0.001 1.2 (1.03,1.48) 0.020 
Triglycerides
  
(mmol/l) 0.99 (0.8, 1.2) 0.9 1.4 (1.1, 1.76) 0.004 
Creatinine (μmol/l) 1(0.99, 1.09) 0.76 1 (0.98, 1.01) 0.983 
     
R
2  
% 38  36  
Area under ROC Curve 0.81  0.81  
 95 
Table 3.5 Multivariable Predictors for Extent of CAC 
 
Variable 





   
Race (SA Vs E) 0.9 (0.74, 1.0) 0.04 
Model 2
   
Race (SA Vs E) 1.1 (0.5, 1.3) 0.3 
Age (10 years) 3.0 (2.7, 3.3) <0.001 
Gender (Male Vs Female) 4.0 (3.8, 4.3) <0.001 
Model 3
   
Age
 
( 10 Years) 2.8 (2.5, 3.1) <0.001 
Body Mass index 1.04 (1.02, 1.06) <0.001 
Current Smoker 1.8 (1.4, 2.4) <0.001 
Former Smoker 1.2 (0.9, 1.5) 0.1 
Statin Use 2.3 (1.8, 3.0) <0.001 
Diabetes 1.7 (1.4, 2.2) <0.001 
Hypertension 1.7 (1.4, 2.0) <0.001 
HDL Cholesterol mmol/l 0.97 (0.9, 1.03) 0.85 
LDL Cholesterol
  
mmol/l 1.02 (1.01, 1.03) <0.001 
Triglycerides mmol/l 1.0 (0.9, 1.02) 0.2 
   
Gender (Male vs Female) 3.8 (3.1, 4.8) <0.001 
Race (SA Vs E) 1.05 (0.9, 1.3) 0.6 
 
Change in odds for increasing extent of CAC, per unit increase in risk factor, 
adjusted for other variables using ordinal regression 
 
Model 1: Unadjusted OR  
Model 2: Adjusted for age and gender 
Model 3: Adjusted for standard risk factors
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Change in odds for increasing extent of CAC, per unit increase in risk factor, 6 
adjusted for other variables using ordinal regression 7 
 8 
9 
 South Asians 
OR (95% CI) 
P Europeans 




( 10 Years) 2.8 (2.4, 3.2) <0.001 2.8 (2.4, 3.2) <0.001 
Gender (Male Vs 
Female) 
4.2 (3.2, 5.6) <0.001 3.8 (2.7, 5.3) 
<0.001 
Hypertension  1.7 (1.3, 2.2) <0.001 1.7 (1.3,2.2) <0.001 
Diabetes 1.8 (1.4, 2.4) <0.001 1.6 (0.96, 2.6) 0.06 
Current Smoker 1.6 (1.1, 2.5) 0.03 1.9 (1.4, 2.8) <0.001 
Former Smoker 0.9 (0.6, 1.3) 0.5 1.4 (1.09, 1.9) 0.02 
     
Statin Use 2.4 (1.7, 3.4) <0.001 2.3 (1.5, 3,7) <0.001 
Body Mass index 
(kg/M
2
) 1.1 (1.03, 1.1) <0.001 1.02 (0.98, 1.05) 0.2 








 1.03 (1.02, 1.05) <0.001 1.02 (0.97, 1.03) 0.05 
Triglycerides
  
(mmol/l) 0.9 (0.9, 1.01) 0.7 1.02 (1.0 , 1.04) 0.02 
     
R2% 39%  38%  
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Figure 3.1 demonstrates the increasing prevalence of CAC among South Asians 6 
















Figure 3.2 demonstrates the Mean Coronary Artery Calcification Scores in All 9 
Participants Divided By Age, Gender and Ethnicity, the error bars represent 10 





Chapter 4: Prevalence of Silent myocardial Ischemia among asymptomatic 1 
South Asians and Europeans  2 
 3 
4.1 Abstract 4 
 5 
Background:  Coronary heart disease (CHD) mortality is 70% higher amongst South 6 
Asians (SA) than Europeans (E), the reasons for this excess remain unexplained. 7 
Coronary artery calcification (CAC) is highly correlated with coronary plaque burden 8 
and silent myocardial ischemia in Europeans; but fails to identify excess risk in South 9 
Asians. We hypothesised that South Asians have a higher prevalence of silent 10 
myocardial ischemia compared to Europeans, despite similar CAC, and this may 11 
explain their excess CHD mortality. 12 
 13 
Methods: I measured CAC for 2369 asymptomatic men and women, aged 35 to 14 
75 years, as part of the London Life Sciences Population (LOLIPOP) study. 518 15 
subjects had CAC scores > 100 Agatston units and of these 256 (49%) patients 16 
underwent Myocardial perfusion scintigraphy (MPS).  17 
 18 
Results: CAC scores were similar among South Asians and Europeans, after 19 
adjustment for conventional risk factors.  MPS abnormalities were seen in 56 (22%) 20 
subjects. Presence of diabetes (P=0.03) and increasing CAC (P< 0.001) were 21 
independent predictors for severity of silent myocardial ischemia. Ethnicity did not 22 




Conclusion: I demonstrated that MPS did not identify greater ischemia among South 1 
Asians compared with Europeans. This appears incongruent with almost 2-fold higher 2 




  1 
4.2 Introduction:  2 
South Asians (people originating from India, Pakistan, Bangladesh and 3 
SriLanka) account for almost a quarter of the global coronary heart disease (CHD) 4 
deaths (1). South Asians (South Asians) form the largest ethnic minority group (4% 5 
of the total population) in the UK, and continue to demonstrate a two-fold higher 6 
coronary heart disease mortality rate (4) in contrast to the decline in CHD-related 7 
mortality in the general population. 8 
While global registries such as the INTERHEART study (5) suggest an 9 
important role of traditional cardiovascular risk factors in coronary heart disease in all 10 
ethnic groups, traditional risk factors (8,47,192) and risk scores such as the 11 
Framingham function do not predict the higher coronary heart disease mortality in 12 
South Asians (109). Therefore, it stands to reason that a high percentage of South 13 
Asians at an elevated risk for cardiovascular disease might remain undetected within 14 
the general population, due to a lack of accurate and robust risk stratification tools.  15 
Coronary artery calcium (CAC) imaging has a strong correlation with 16 
atherosclerotic plaque disease, with amount of CAC directly related to the total 17 
atherosclerotic plaque burden and severity of coronary disease (144,153). CAC does 18 
not, however, appear to identify the excess coronary risk seen among South Asians 19 
compared with Europeans (173).  20 
MPS is a well validated technique for the non-invasive diagnosis of coronary 21 
artery disease (180,208) and presence of stress related ischemia on MPS is strongly 22 




Previous studies have demonstrated an increasing prevalence of stress-induced 1 
ischemia detected by MPS with CAC >100 Agatston units. This has been 2 
demonstrated among patients suspected to have CHD (179,184) as well as 3 
asymptomatic healthy subjects (140,185). However, there is negligible ischemia 4 
demonstrated among subjects with low/ absent coronary calcium by several studies 5 
including those performed by our group (140,179,184,186). Therefore, MPS is often 6 
used in conjunction with CAC imaging; with CAC providing a screening test for 7 
detecting presence of atherosclerotic coronary artery disease and MPS providing a 8 
functional assessment of severity of stenosis.  9 
While South Asians have a higher coronary heart disease risk and mortality 10 
compared with Europeans(4), it has been shown that they display similar burden of 11 
calcified atherosclerotic plaque, as detected by CAC imaging (173,204). We 12 
hypothesised that South Asians have more obstructive coronary artery disease as 13 
exemplified by a greater prevalence of reversible silent myocardial ischemia despite 14 
similar burden of calcified coronary plaque, compared with Europeans. Therefore, the 15 
aim of the study was to assess whether MPS helps identify the excess coronary heart 16 





4.3 Methods: 1 
Participants: All subjects were recruited from the London Life Sciences 2 
Population (LOLIPOP) study. While the methods for the study have been described 3 
in detail in the methods and materials chapter a brief overview follows.  4 
 2369 asymptomatic South Asians and Europeans men and women were 5 
recruited from the LOLIPOP study, to undergo CAC imaging using electron beam 6 
computed tomography (EBCT). As previous work by our group and others has 7 
demonstrated negligible prevalence of silent myocardial ischemia among subjects 8 
with CAC of less than 100 Agatston units (140,179,184) , in order to minimise the 9 
number of subjects exposed to radiation, a cut-off value of 100 Agatston units was 10 
used to select participants for MPS. 518 patients had CAC > 100 Agatston units and 11 
were invited for MPS. Out of these, 256 (49%) participants consented to undergo 12 
MPS. Subjects who participated in the perfusion study were comparable with those 13 
who did not, on CAC scores and most standard coronary risk factors, with the 14 
exception that they were 2 years younger, with a higher statin use along with lower 15 
HDL cholesterol levels. The characteristics of participants and non-responders are 16 
shown in Table 4.1.  17 
 18 
Coronary artery calcification: CAC imaging was performed using a 19 
modified GE Imatron C-150 (San Francisco, CA, USA) specially equipped with high-20 
resolution detectors, at the Cardiac Imaging and Research Centre, Wellington 21 
Hospital. Coronary visualization was performed without contrast. In order to include 22 
the entire coronary tree, forty contiguous 3-mm slices were obtained during a single 23 
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breath-hold, starting at the carina and proceeding to the level of the diaphragm. Scan 1 
time was 100-ms per slice, synchronised to 40% of the R-R interval(189).  2 
Myocardial perfusion Scintigraphy: MPS was performed using a 2-3 
day protocol (stress and rest) with Technitium-99m sestamibi. For stress imaging, 4 
either a maximal stress exercise treadmill test (Bruce protocol) in conjunction with 5 
pharmacologic stress using dipyridamole (190) or  dobutamine stress test (191) was 6 
used. This method has been validated by our laboratory and others, and has been 7 
found to increase specificity compared with using only exercise/ pharmacological 8 
stress. Stress and rest MPS images were acquired 60 to 120 minutes after injection of 9 
600 MBq Tc-99m sestamibi by use of a large field-of-view, dual-headed gamma 10 
camera equipped with a high-resolution collimator (SMV DSTi; GE Medical 11 
Systems, Buc Cedex, France). Thirty-two projections (40 seconds per projection) 12 
were acquired over a 180° arc, from the 45° right anterior oblique position to the 45° 13 
left posterior oblique position. Strict quality control and motion artefact correction 14 
were used. 15 
 16 
Image Interpretation:  17 
Coronary artery calcification: All areas of calcification within the 18 
borders of a coronary artery with an optical density above 130 Hounsfield units and 19 
an area greater than 1 mm
2
 were computed. CAC scores were calculated on an 20 
Aquarius workstation (TeraRecon, Inc., San Mateo, USA) and scores between 21 
participants were adjusted with a standard calcium phantom. The output from EBCT 22 
scans was quantified into Agatston scores as described by Agatston et al(157). Due to 23 
the non-Gaussian nature of CAC, statistical analyses were carried out using Agatston 24 
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score transformed to their natural logarithm (loge). For the purpose of analysis the 1 
CAC score was used as a categorical trait, defined as Agatston score 100-400 Au and 2 
>400 Au.   3 
Myocardial perfusion Scintigraphy: Stress-rest Tc-99m sestamibi 4 
MPS scans were interpreted by semi-quantitative visual analysis, and the findings 5 
were categorised for overall interpretation as normal or abnormal.  The MPS scans 6 
were reported by an independent observer (A.L.) blinded to the clinical, ethnic group 7 
and coronary calcium data. Semi-quantitative visual analysis was performed by use of 8 
the 17-segment model recommended by the American College of 9 
Cardiology/American Heart Association/American Society of 10 
Echocardiography/American Society of Nuclear Cardiology. Tracer uptake was 11 
scored in each segment by use of a 5-point scoring system (0, normal; 1, equivocal; 2, 12 
moderate; 3, severe reduction of radioisotope uptake; and 4, apparent absence of 13 
tracer uptake). Total ischemic burden was estimated using summed stress, rest, and 14 
difference scores (SSS, SRS, and SDS). SSS and SRS were determined by the sum of 15 
scores of each segment from the stress and rest images, respectively. 16 
 A SSS >4 was considered to be abnormal. Summed difference scores (SDS) 17 
were determined by the sum of the difference between the SSS and the SRS.  The 18 
SDS was converted to percent myocardium ischemia by dividing the SDS by 68—the 19 
maximum potential score (4 X 17)—and multiplying by 100.(179) Due to the high 20 
prevalence of participants with no detectable ischemia on MPS, the distribution of 21 
myocardial ischemia was highly skewed and could not be transformed back to 22 
normality. Hence, it was evaluated as a categorical variable, i.e. absence of reversible 23 
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myocardial ischemia (0%), mild defect (<5%), moderate defect (>5 and ≤10%), or 1 
large defect (>10%).  (209). 2 
Statistical analysis: All analyses were performed using the statistics 3 
programme Statistical Package for the Social Sciences (SPSS) version 16.0 (Chicago, 4 
IL, USA). Categorical data are presented as number (percent), and continuous data as 5 
mean value± SD. The chi-square test was used to compare categorical variables while 6 
comparisons of continuous variables between two groups were performed using 7 
student t tests. All tests of significance were two-tailed, and significance was defined 8 
at the ≤0.05 level.  9 
Prevalence and extent of myocardial ischemia was compared across ethnic 10 
groups. The relationships between risk factors and myocardial ischemia were 11 
analysed using regression models, both before and after adjusting for concomitant 12 
risk factors. While a binomial logistic regression model was used to evaluate 13 
associations between risk factors and the presence of MPS abnormalities, an ordinal 14 
regression analysis was applied to identify clinical predictors of severity of 15 
myocardial ischemia. The resultant estimates (ordered log odds), were exponentiated 16 
to calculate the odds ratios of the predictors. From these models, an odds ratio and 17 
95% confidence interval was calculated. The variance explained by the models was 18 






4.4 Results 1 
Clinical characteristics of subjects 2 
The clinical and biochemical characteristics of the participants are described 3 
in Table 4.2. South Asians were on average 2 years younger, with a higher prevalence 4 
of hypertension and diabetes. They also demonstrated a higher statin usage and 5 
elevated serum HbA1c levels compared with Europeans. South Asians also had a 6 
lower BMI, HDL levels, and smoking rates compared with Europeans. Accordingly, 7 
South Asians had a higher prevalence of metabolic syndrome as defined by the NCEP 8 
criteria, however, similar Framingham risk scores. Unadjusted CAC scores suggested 9 
a tendency towards lower CAC among South Asians compared with Europeans (P 10 
0.06). 11 
MPS was performed on 256 participants. Perfusion abnormalities were seen in 12 
56 (22%) subjects, the majority (89%) of which were reversible defects. Prevalence 13 
(Figure 4.1) and extent (Figure 4.2) of myocardial ischemia were compared across 14 
CAC categories, and were seen to increase in parallel with CAC scores among South 15 
Asians and Europeans. There was no significant difference in extent or severity of 16 
myocardial ischemia among South Asians compared with Europeans.  17 
 18 
Predictors of presence of myocardial ischemia  19 
Univariable analysis demonstrated increasing age and higher CAC category, 20 
as well as presence of diabetes to be associated with elevated odds for the presence of 21 
myocardial ischemia (SSS>4). A multivariable logistic regression model, including 22 
conventional cardiovascular risk factors along with ethnicity, explained about 14% of 23 
the variation in myocardial perfusion defects in this population (Table 4.3a). After 24 
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adjustment for cardiovascular risk factors, ethnicity was not related to presence of 1 
myocardial ischemia, OR= 0.9 (95% CI 0.4, 2.0). ). Increase in CAC was a significant 2 
predictor associated with presence of myocardial ischemia (p 0.001), with presence of 3 
diabetes demonstrating borderline statistical significance (p 0.07). Multivariable 4 
regression model were repeated using predictors with p<0.2 (Table 4.3b). The model 5 
demonstrated a good fit, with a chi square significance of 0.7, and explained about 6 
8% of the variation. The results, however, remained same. CAC and DM were the 7 
only predictors of perfusion defects (Table 4.3b).   8 
 9 
Predictors of severity of ischemia  10 
A univariable ordinal regression demonstrated increasing age, increasing 11 
CAC, presence of diabetes and hypertension, as well as a history of statin usage to be 12 
associated with elevated odds for the presence of myocardial ischemia. However, on 13 
adjusting for conventional cardiovascular risk factors and ethnicity, using a 14 
multivariable ordinal regression model, an increase in CAC and presence of diabetes 15 
mellitus were independently associated with abnormal myocardial perfusion and 16 
increasing severity of ischemia. After adjustment for cardiovascular risk factors, 17 
ethnicity was not related to the severity of myocardial perfusion defects OR 1.08 18 
(95% CI 0.6, 2.0). Multivariable regression model were repeated using predictors 19 
with p<0.2 (Table 4.4b). The model demonstrated a good fit, with a chi square 20 
significance of 0.8, and explained about 9% of the variation. The results remained 21 
consistent, and high CAC and DM were the only predictors of perfusion defects. 22 





4.5 Discussion 1 
In this cohort of asymptomatic South Asians and, aged between 35 and 75, 2 
with CAC scores greater than 100 Agatston units; we found no ethnic differences in 3 
either prevalence or extent of myocardial perfusion defects among South Asians and 4 
Europeans. This is incongruent with almost 2-fold higher risk of myocardial 5 
infarction and coronary heart disease mortality observed in South Asians. MPS did 6 
not predict or identify the excess coronary heart disease risk in South Asians in this 7 
sample 8 
Consistent with existing data, we found a higher frequency of both present 9 
and former smokers among Europeans compared with South Asians, with a lower 10 
prevalence of diabetes and hypertension (7,8,10,108,174). CAC was the strongest 11 
predictor of the prevalence of myocardial perfusion defects. In addition, an increase 12 
in CAC was associated with concomitant elevation in the prevalence and extent of 13 
myocardial ischemia (140,179,210). Diabetes mellitus was a predictor of myocardial 14 
ischemia, consistent with existing data (210-212), and also corroborating previous 15 
research which has demonstrated a higher prevalence of perfusion defects in diabetic 16 
populations (140). 17 
 While the overall prevalence of perfusion defects in our population is 18 
consistent with previous studies, we demonstrated a lower prevalence of severe 19 
myocardial perfusion defects (184). This could be because of the asymptomatic 20 
population selected for our study compared with physician-referred symptomatic 21 
participants used in other studies.  To our knowledge, this is the first population-22 
based study evaluating the prevalence and extent of silent myocardial ischemia using 23 
MPS among asymptomatic South Asians in comparison with Europeans.  24 
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There is little data available which compares ethnic differences in prevalence 1 
and prognostic implications of silent ischemia on MPS. Shaw et al (187), in a study 2 
carried out among AA and NW populations, demonstrated a higher prevalence of 3 
moderate to severe myocardial perfusion defects among AA compared with NW. 4 
However, follow up from the study identified a greater risk of events among AA for 5 
all grades of perfusion abnormalities as compared with NW, both before and after 6 
adjustment for cardiovascular risk factors. This suggests an increased cardiovascular 7 
risk among AA compared with NW, irrespective of the detected burden of obstructive 8 
coronary artery disease. The lower percentage of obstructive coronary artery disease 9 
in AA when compared with NW among patients referred for acute coronary 10 
syndromes (213) and lower percentage of coronary stenosis despite higher CHD 11 
mortality and prevalence compared with NW (170,172), lends strength to this 12 
argument. It also highlights the importance of factors other than atherosclerotic 13 
plaque burden in the prediction of cardiovascular events. 14 
 AA have higher prevalence of cardiovascular risk factors such as diabetes, 15 
hypertension and smoking, and higher cardiovascular mortality compared with 16 
Caucasians, however have been identified as having higher mortality for similar 17 
degrees of obstructive coronary disease both on angiography and MPS. This supports 18 
a greater role of physiological abnormalities, as opposed to a greater atherosclerotic 19 
plaque burden, in causing adverse cardiovascular events in AA. Thus, ethnic disparity 20 
in coronary heart disease risk and mortality might be better explained by differences 21 
in plaque morphology and composition rather than atherosclerotic plaque burden.  22 
In this cohort, South Asians exhibit higher levels of diabetes, hypertension, 23 
and lower levels of smoking, compared with Europeans. They, however, demonstrate 24 
111 
 
similar coronary artery calcification. This lack of difference persists even after 1 
adjusting for standard risk factors including smoking, diabetes and hypertension. 2 
Furthermore, our data also show a similar prevalence and extent of myocardial 3 
perfusion defects among UK South Asians and Europeans, for comparable levels of 4 
CAC. These results contrast with the excess coronary heart disease risk observed in 5 
South Asians, and have several potential implications. Firstly, this could signify that, 6 
while the atherosclerotic plaque burden is similar among the two populations, there 7 
are differences in plaque composition between South Asians and Europeans. There is 8 
thus a greater vulnerability of plaque in South Asians, compared with Europeans and 9 
results in a higher propensity of plaque to rupture or undergo thrombosis. The second 10 
implication could be that a higher degree of systemic inflammation or elevated levels 11 
of prothrombotic factors exist in South Asians, compared with Europeans, which 12 
exposes them to higher coronary heart disease risk irrespective of atherosclerotic 13 
plaque burden.  14 
The differences in prevalence of risk factors could therefore portent potential 15 
differences in the mechanism of plaque initiation among the two populations resulting 16 
in similar burden of atherosclerosis and thus coronary calcification, but differences in 17 
subsequent morphology of atherosclerotic plaque. 18 
Studies in animal models, as well as those among  human cases of sudden 19 
death, have demonstrated increased macrophage activity in plaques which underwent 20 
rupture and subsequent thrombosis (51). Moreover, studies in human subjects have 21 
shown markedly increased inflammation within active atherosclerotic plaques in 22 
carotid arteries (52,53). These factors support the role of inflammation as one of the 23 
key factors in initiation and progression of vulnerable atherosclerotic plaques (49).  24 
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South Asians exhibit a high prevalence of metabolic factors such as diabetes, 1 
hypertension and abdominal obesity, with lower HDL cholesterol levels (54-57). The 2 
presence of these risk factors is associated with greater inflammation (58,59). 3 
Furthermore, South Asians also demonstrate elevated levels of C-reactive protein 4 
(CRP) (60), from ages as low as 9-10 year (57). CRP is an important marker of 5 
inflammation, with elevated levels of CRP strongly associated with increased 6 
macrophage activity within plaques (63,64), and is considered an independent 7 
predictor of future cardiovascular events (51,65). The recently published JUPITER 8 
trial further highlights the importance of inflammation by demonstrating substantial 9 
decreases in cardiovascular events in low risk populations following reductions in 10 
CRP levels (205).  11 
In addition to these biological factors, South Asians have also been shown to 12 
demonstrate high levels of psychosocial stress, as well as experiencing greater 13 
chronic stress, compared with Europeans (91).  Psychosocial stress has been shown to 14 
further stimulates the activation of the sympathetic nervous system, cause endothelial 15 
dysfunction and release of proinflammatory cytokines and prothrombotic responses 16 
which in turn promote atherogenesis (88). Furthermore, stress has also been found to 17 
be correlated to CAC (99), and to silent myocardial ischemia, further lending strength 18 
to the argument (100). 19 
While these factors are known to be associated with accelerated atherogenesis 20 
and increased thrombogenecity, and their exact role in the excess coronary heart 21 
disease in South Asians is not ascertained, their elevated levels are likely to be 22 




Conclusions  1 
 In conclusion, I demonstrated that ethnicity was not related to the severity or 2 
extent of silent myocardial ischemia, after adjustment for cardiovascular risk factors. 3 
The higher coronary heart disease risk and mortality observed in South Asians is not 4 
identified by markers of atherosclerotic burden such as CAC and MPS. This suggests 5 
a greater contribution of factors such as plaque morphology and inflammation in the 6 
higher coronary heart disease mortality observed among South Asians, however, the 7 
extent to which it explains the excess CHD risk observed among South Asians 8 





Table 4.1 Characteristics of responders and non responders for myocardial perfusion imaging 1 
 Responders Non responders P value 
Age (Years)  63±8 65±8 0.003 
Agatston score(95% CI) 599±763 566±663 0.79 
Body mass index 27.4±3.9 28.07±4.6 0.07 
    
Former smoker % 28 26 0.62 
Current smokers (%) 12.8 12.3 0.32 
    
Type 2 diabetes (%) 28 24.8 0.17 
Serum Glucose (mmol/L) 6.3±2.3 6.2 ±2.2 0.853 
    
Total cholesterol (mmol/l) 5.35±1.17 5.5±1.13 0.132 
Triglycerides (mmol/L) 1.65±0.88 1.72±1.14 0.476 
HDL cholesterol (mmol/l) 1.26±0.29 1.33±0.35 0.016 
LDL cholesterol (mmol/l) 3.3±0.9 3.4±0.0 0.291 
    
History of Hypertension 
(%) 
50 46 0.192 
Systolic Blood Pressure 
(mmHg) 
140±18 145±20 0.32 
Diastolic Blood Pressure 
(mmHg) 
82±10 82±11 0.74 
MS-IDF % 20 20 0.71 




Table 4.2: Characteristics of Participants 1 
 European (100) South Asian (156) P value 
Age (Years) 64 ± 7 62±8  .004 
Agatston score (95% CI) 696 (535-857) 530(421-639) 0.06 
Hypertension (%) 38 62 <0.001 
Systolic Blood Pressure 81±10 83±10 0.38 
Diastolic Blood Pressure 140±18 140±17 0.9 
    
BMI 28±4.5 27±3.3 <0.001 
Type 2 diabetes (%) 18 39 <0.001 
Serum Glucose (mmol/l) 5.9±2.0 6.5±2.5 0.037 
HbA1c  5.7±1.2 6.4±1.4 <0.001 
    
Current smokers (%) 21 9 0.003 
Former smoker (%) 54 12.5 <0.001 
    
On Statins (%) 21 33 0.03 
Total cholesterol (mmol/l) 5.4±1.19 5.2±1.14 0.086 
LDL Cholesterol (mmol/l) 3.3±0.9 3.4±1 0.15 
HDL cholesterol (mmol/l) 1.3±0.32 1.19±0.25 <0.001 
Triglycerides (mmol/l) 1.6 ± 0.85 1.7±0.89 0.438 
    
Metabolic syndrome (NCEP) 
% 
13% 25% 0.02 




Table 4.3a Multivariable Predictors of Presence of Perfusion Defect 1 
Risk Factor Odds ratio (95% CI) P value 
Age (10 Yrs) 1.1 (0.7, 1.8) 0.6 
Loge CAC 
3.6 ( 1.5, 8.9) 0.004 
Hypertension 1.1 (0.54, 2.2) 0.9 
Body Mass Index (Kg/M
2
) 1.06 (0.9, 1.2) 0.2 
   
Diabetes Mellitus 2.3 ( 0.9, 5.9) 0.1 
HbA1c (%) 0.8 (0.6, 1.2) 0.3 
   
Former Smoker (Vs Non 
smoker) 
0.62 (0.3, 1.5) 0.3 
Current Smoker (Vs Non 
smoker) 
1.3 (0.5, 3.7) 0.6 
   
HDL Cholesterol (mmol/l) 0.56 ( 0.2, 1.9) 0.4 
Statin Usage 1.2 (0.6, 2.7) 0.5 
   
Ethnicity ( SA Vs E) 0.89 (0.4, 2.0) 0.8 
  2 
Change in odds for presence of perfusion defects, per unit increase in risk factor, adjusted for 3 
all other variables using logistic regression  4 
 5 
 6 









Table 4.3b Multivariable Predictors of Presence of Perfusion Defect 2 
Risk Factor Odds ratio (95% CI) P value 
CAC category 2.6 ( 1.4, 4.9) 0.003 
   
Diabetes Mellitus 1.7 ( 0.9, 3.3) 0.09 
  3 
Change in odds for presence of perfusion defects, per unit increase in risk factor, adjusted for 4 









Odds ratio (95% CI) P value 
Age (10 Yrs) 1.06 (0.7, 1.6) 0.8 
Ethnicity ( SA Vs E) 1.08 (0.6, 2.0) 0.8 
Loge CAC  4.09 (2.0, 8.02) <0.001 
   
History of Hypertension 0.99 (0.5, 1.8) 0.9 
Type 2 Diabetes 2.2 (1.1, 4.5) 0.03 
HbA1C 0.88 (0.7, 1.1) 0.2 
Body Mass Index (Kg/M
2
) 1.06 (0.9, 1.1) 0.1 
   
Former smoker(Vs Non Smokers) 0.68 (0.3, 1.7) 0.5 
Current Smoker (Vs Non 
Smokers) 
1.24(0.5, 2.9) 0.6 
   
Statin usage 1.2 (0.7, 2.2) 0.5 
HDL Cholesterol (mmol/l) 0.72 (0.3, 1.9) 0.5 
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Change in odds for increase in severity of perfusion defects, per unit increase in 6 







Odds ratio (95% CI) P value 
CAC Category 2.7 (1.6, 4.7) 0.001 
   
Type 2 Diabetes 1.9 (1.1, 3.4) 0.02 
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Figure 4.1 Prevalence of myocardial perfusion abnormalities among South 1 




















Figure 4.2 Severity of Myocardial Perfusion Abnormalities among 1 















Chapter 5: C reactive protein among South Asians and Europeans 1 
and its relationship with CAC and MPS  2 
 3 
5.1 Abstract 4 
 5 
Background: Coronary heart disease mortality is 70% higher amongst UK 6 
South Asian compared with Europeans. Traditional risk factors do not consistently 7 
predict the higher CHD risk.  Markers of coronary plaque burden and stenosis, such 8 
as coronary artery calcification and myocardial perfusion imaging, do not identify the 9 
higher CHD risk observed among South Asians. Inflammation is a key factor in 10 
initiation and progression of atherosclerosis (49,50). High sensitivity C-reactive 11 
protein (CRP) is an important marker of active inflammation and is considered an 12 
independent predictor of future cardiovascular events (51,65).We hypothesised that 13 
South Asians have greater degree of systemic inflammation as measured by plasma  14 
CRP, compared with Europeans. The greater degree of inflammation may provide an 15 
explanation for their higher CHD risk despite similar coronary plaque burden. 16 
 17 
Methods:  The study comprised 2347 asymptomatic South Asians and 18 
Europeans men and women, aged 35 to 75 years, part of the London Life Sciences 19 
Population (LOLIPOP) study. Anthropometric measurements, biochemical markers 20 
including CRP, and atherosclerosis imaging using coronary artery calcification were 21 
performed for all subjects. 256 subjects (49% of those coronary calcification scores> 22 
100 Agatston units) also underwent myocardial perfusion scanning.   23 
   24 
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Results: High sensitivity CRP levels were higher among men than 1 
women, and were closely associated with age, cigarette smoking, hypertension, 2 
HbA1C, total cholesterol and BMI. CRP levels were higher among South Asians 3 
compared with Europeans, both before and after adjustment for the measured 4 
cardiovascular risk factors. CRP was not associated with higher CAC levels or higher 5 
degree of myocardial ischemia, for either ethnicity.  6 
 7 
Conclusions: South Asians have higher levels of CRP compared with Europeans. 8 
This difference remained despite adjusting for conventional risk factors. CRP levels 9 
were not correlated with CAC or myocardial ischemia.  While markers of 10 
inflammation remain consistently elevated among South Asians, this does not 11 
correlate with atherosclerotic plaque burden.  12 
Though further research is needed to assess the mechanism of aggressive 13 
coronary artery disease and resultant high mortality among South Asian, our study 14 
suggests a role of inflammation beyond what is measured by plaque burden.15 
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5.2 Introduction:  1 
South Asians (people originating from India, Pakistan, Bangladesh and 2 
SriLanka) account for almost a quarter of the global coronary heart disease (CHD) 3 
deaths (1). Within the UK, they form the largest ethnic minority group (4% of the 4 
total population). While improvements in health care have resulted in a decline in 5 
CHD-related mortality in the general population, South Asians (SA) continue to 6 
demonstrate a two-fold higher coronary heart disease mortality rate (4). A recent 7 
meta-analysis including 6 studies and over 100,000 subjects assessing acute coronary 8 
syndromes also suggests higher incidence (214) among this population.  9 
The reasons for this excess CHD risk are not well elucidated. While global 10 
registries such as the INTERHEART study suggest an important role of traditional 11 
cardiovascular risk factors in coronary heart disease (5), South Asians do not 12 
consistently demonstrate higher prevalence of such risk factors. Further, neither such 13 
factors (8,47,192), nor risk scores comprising them such as the Framingham function, 14 
accurately predict the higher coronary heart disease mortality in South Asians (109). 15 
Many theories have been postulated in order to explain this unexpected higher CHD 16 
risk observed among South Asians. These include possible elevated plaque burden i.e. 17 
higher levels of atheroma and percentage stenosis (215), as well as excess 18 
inflammation and elevated levels of prothrombotic molecules (9,12,72).  19 
Over the last few decades, accurate non invasive assessment of coronary 20 
plaque has become available and gained acceptance. Among such techniques, 21 
coronary artery calcium (CAC) imaging and myocardial perfusion scintigraphy 22 
(MPS) have been extensively used and validated.  23 
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CAC has a strong correlation with severity of coronary disease (144,153), 1 
with increasing utilization as a measure of plaque burden. MPS assess functional 2 
severity of coronary artery stenosis. There is now growing evidence to show higher 3 
mortality in subjects with high CAC levels, and in those with higher levels of ischemia 4 
seen on MPS, irrespective of concomitant risk factors thus increasing predictive value of 5 
risk factor assessments (134,216-218). Alternately, low calcium levels and absence of 6 
inducible ischemia on MPS have been shown to identify subjects with very low (<1% 7 
per year) risk of coronary events (143). However, CAC and MPS do not appear to 8 
identify the excess coronary risk seen among South Asians (173). While this lack of 9 
difference in physical markers of CHD among Indians and Europeans is unexpected 10 
in the first instance, it appears to be very appropriate given the growing body of 11 
evidence which highlights the importance of inflammation in atherosclerosis and 12 
plaque instability. Thus physical markers of disease will be unable to address plaque 13 
morphology and composition, the presence of calcified versus inflammatory plaque, 14 
and the role of inflammation in CHD (219).  15 
Prospective studies in healthy subjects have demonstrated an independent 16 
association between systemic inflammation and vascular events. Inflammation plays a 17 
significant role in the atherothrombotic process, including the sudden rupture of 18 
apparently stable plaque that is the underlying immediate cause of most acute 19 
vascular events (116). Components of both the innate and acquired immune systems 20 
are relevant to this progression (220).  Inflammation appears to be inherent to the 21 
complex interaction of lipid accumulation and immune function which promotes 22 
premature atherosclerosis and accelerate plaque fissuring, a process that exposes the 23 
underlying matrix to circulating thrombogenic factors and ultimately leads to platelet 24 
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activation and adhesion to the vessel wall causing vessel occlusion, and downstream 1 
hypoxia.  2 
 Among such markers of inflammation, high-sensitivity CRP, an acute phase 3 
reactant, has been arguably the most extensively studied of such molecules. While it 4 
is as yet unclear whether the CRP is causative in the process of inflammation its 5 
importance is in identification of high risk patients.  Elevated levels of CRP are 6 
associated with increased macrophage activity within plaques (63,64) and with a 7 
higher density of high risk mixed coronary plaques (221). Presence of elevated CRP 8 
levels in subjects with non calcified plaque has been associated with an increased 9 
incidence of cardiovascular events (222). Increased concentrations of CRP have been 10 
shown in both clinical and epidemiological studies to be associated with 11 
atherothrombotic events. It is considered an independent predictor of future 12 
cardiovascular events (51,65) improving risk stratification when added to 13 
conventional risk factors (223,224). 14 
South Asians exhibit a high prevalence of diabetes mellitus, hypertension, 15 
abdominal obesity and metabolic syndrome, with lower HDL cholesterol levels (54-16 
57). Presence of these risk factors is associated with greater systemic inflammation 17 
(58,59).  We therefore hypothesised that South Asians have a higher degree of 18 
inflammation, which can be assessed using CRP. This may explain the higher CHD 19 





5.3 Methods: 2 
Participants: 2347 asymptomatic South Asians and Europeans men and 3 
women were recruited from the LOLIPOP study. The main LOLIPOP study has been 4 
described in detail in methods chapter. All subjects underwent extensive imaging 5 
including CAC imaging using electron beam computed tomography (EBCT), as well 6 
as anthropometric measurements and biochemical markers including CRP. Patients 7 
with CAC > 100 Agatston units also underwent MPS studies.  8 
 9 
Coronary artery calcification and myocardial perfusion scintigraphy:  10 
The methods for the imaging modalities have been described in detail in the methods 11 
and materials chapter.  12 
 13 
High sensitivity C reactive protein: CRP was measured by automated 14 
microparticle enhanced turbidometric immunoassay run on COBAS MIRA (Roche 15 
Diagnostics GMbH). 16 
 17 
Statistical analysis: All analyses were performed using the statistics 18 
programme Statistical Package for the Social Sciences (SPSS) version 21.0 (Chicago, 19 
IL, USA). Categorical data are presented as number (percent), and continuous data as 20 
mean value± SD. The chi-square test was used to compare categorical variables while 21 
comparisons of continuous variables between two groups were performed using 22 
student t tests. All tests of significance were two-tailed, and significance was defined 23 
at the ≤0.05 level.  24 
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Levels of CRP were compared across ethnic groups. The relationships 1 
between conventional risk factors and CRP were analysed using regression models, 2 
both before and after adjusting for concomitant risk factors. A binomial logistic 3 
regression model was used to evaluate associations between risk factors and the 4 
presence of high CRP levels using 2mg/L as a cutoff (205). A separate linear 5 
regression model was used to assess the predictive ability of risk factors for the 6 
increase in CRP. Due to the non-Gaussian nature of CRP, analyses were carried out 7 
using CRP transformed to their natural logarithm (lge). The resultant beta coefficients 8 






5.4 Results: 2 
Clinical and biochemical characteristics of patients 3 
South Asians were on average two years younger than Europeans, with a 4 
higher percentage of women. They demonstrated a higher prevalence of diabetes 5 
mellitus, hypertension and metabolic syndrome with lower prevalence of current and 6 
ex-smokers. South Asians also had higher serum glucose and triglycerides levels with 7 
lower total cholesterol, HDL and LDL cholesterols, as well as physical activity index 8 
compared with Europeans. South Asians had a similar BMI, though a higher waist hip 9 
ratio and body fat percentage and 16% of South Asians were on cholesterol lowering 10 
medications compared with 8% of Europeans. Log CRP levels were higher in South 11 
Asians compared with Europeans (Table 5.1).  12 
 13 
Predictors of CRP 14 
Univariate linear regression was carried out in order to assess association of 15 
risk factors with CRP (Table 5.2). Increasing age, LDL cholesterol and triglyceride 16 
levels along with increasing WHR and BMI were associated with increasing levels of 17 
CRP; as was the presence of diabetes, hypertension, and male gender. HDL levels and 18 
statin usage was negatively associated with CRP. South Asian ethnicity was 19 
significantly associated with increasing CRP levels.  20 
Multivariable linear analysis was used to predict effect of conventional risk 21 
factors and ethnicity on CRP levels, and explained 25% of the variation in CRP. It 22 
demonstrated that increase in age, HbA1c, WHR, BMI, was associated with elevated 23 
CRP. Presence of hypertension, male gender and current smoking were also 24 
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associated positively with increasing CRP. Statin usage and HDL levels were 1 
negatively associated with CRP. South Asians ethnicity appeared to be independently 2 
associated with higher CRP levels, even after adjusting for concomitant risk factors. 3 
(Table 5.3) 4 
Ethnic specific analysis showed that among Europeans, increasing age, WHR, 5 
smoking and male gender were associated with increasing CRP. Among South 6 
Asians, DM, WHR and Body fat were associated with elevated CRP. Statin usage and 7 
increasing HDL levels was negatively associated with CRP levels among both 8 
ethnicities.  9 
 10 
CRP as a categorical variable 11 
A multivariable logistic regression model was used to assess effect of 12 
conventional cardiovascular risk factors and ethnicity on high levels of CRP using 2 13 
mg/L as a cut off, and explained about 20% of the variation in CRP in this population. 14 
Increasing WHR and body fat were independently associated with higher levels of 15 
CRP. Statin usage was associated with lower levels of CRP. After adjustment for 16 
cardiovascular risk factors, South Asian ethnicity remained an independent predictor 17 
of a prevalence of elevated CRP, OR=1.4 (95% CI 1.1, 1.7). 18 
 19 
CRP and CAC 20 
There was a weak correlation between CRP and CAC, with a spearman’s 21 
coefficient of 0.06 (p 0.002). CRP levels did not predict either presence or extent of 22 
coronary calcification.  23 
Higher levels of CAC were associated with conventional risk factors including 24 
age, male gender, diabetes and hypertension. While CRP was associated with 25 
increased levels of CAC on univariate linear regression (P = 0.002), this relationship 26 
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was not statistically significant after adjusting for ethnicity and conventional 1 
cardiovascular risk factors (Table 5.4). The results were similar when analysed 2 
separately for South Asians and Europeans.  3 
 4 
CRP and MPS 5 
There was a no correlation between CRP and presence or extent of ischemia 6 
[spearman’s coefficient of 0.05 (p 0.73)]. CRP was not associated with higher 7 
incidence of ischemia on MPS, before or after adjustment for conventional 8 




5.5 Discussion: 1 
In this cohort of asymptomatic men and women, aged 35-75 years, we 2 
demonstrated higher levels of CRP in South Asians compared with Europeans. This 3 
was independent of conventional risk factors. Furthermore CRP was not correlated 4 
with coronary plaque burden as demonstrated by coronary artery calcification and 5 
myocardial perfusion imaging. 6 
South Asians are at a higher risk of coronary artery disease and demonstrate 7 
higher CHD mortality compared to Europeans. This excess risk remains unexplained 8 
and largely undetected by conventional risk stratification tools. Markers of 9 
atherosclerotic plaque burden such as CAC and MPS do not identify the higher risk 10 
seen among South Asians. We hypothesized that South Asians have higher degree of 11 
inflammation compared to Europeans. Quantification of this inflammation using CRP 12 
could provide an accurate assessment of risk in this population. We found that CRP 13 
levels were higher among South Asians both before and after adjusting for 14 
conventional risk factors.   15 
Consistent with existing data, we demonstrated that increasing age, male 16 
gender, LDL cholesterol, HbA1C levels, WHR and body fat were associated with 17 
increase in CRP levels(225,226). Increasing HDL levels and statin usage found to 18 
be negatively associated with CRP.  CRP was not associated with CAC levels 19 
(227,228).  20 
Ethnic differences in CRP have been studied by our group among others. 21 
High levels of CRP been documented among African Americans, Hispanics, and 22 
South Asians compared with Caucasians (60,110,225,229). There are many 23 
theories postulated regarding this excess including increased abdominal obesity 24 
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(230), higher prevalence of diabetes mellitus and insulin resistance (110) i.e. the 1 
dysmetabolic profile as well as chronic stress or lower socio economic status. 2 
Metabolic factors may affect the atherosclerotic process in several ways. They 3 
contribute to lipid accumulation in the artery and initiate new rounds of immune- 4 
cell recruitment. Also, the adipose tissue of patients with the metabolic syndrome 5 
and obesity produces inflammatory cytokines, particularly tumor necrosis factor 6 
and interleukin. There is however no clear answer to the question of cause and 7 
effect regarding adiposity, insulin resistance and systemic inflammation as elevated 8 
cytokines can cause insulin resistance; and insulin resistance with its resulting 9 
abdominal obesity can cause elevation in cytokine levels.  10 
A number of studies have demonstrated association of lower SES with 11 
higher degree of inflammation. This is due to a mix of poor diet, chronic infections, 12 
psycho social stress along with higher incidence of smoking, excess alcohol, 13 
sedentary life. Thus, ethnic variations in inflammation and CRP could be due to an 14 
amalgamation of such factors.  15 
 Irrespective of ethnic variations and differences, measures of 16 
atherosclerotic plaque burden have not been associated with elevated CRP levels in 17 
South Asians and Europeans (226-228,231). These findings suggest separate 18 
pathophysiology in calcified plaque/ obstructive coronary disease and systemic 19 
/focal inflammatory state as demonstrated by higher CRP levels.  20 
Compared with Europeans, South Asians have a similar atherosclerotic 21 
plaque burden but demonstrate a greater degree of systemic inflammation. The 22 
difference remains significant even after adjusting for conventional risk factors, 23 
diabetes and obesity. This is an extremely important finding given that 24 
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inflammation is a key feature of coronary atherosclerosis, and more importantly, 1 
plaque instability. Thus, the unexplained high CHD mortality in South Asians 2 
could be driven by unstable inflammatory plaque as opposed to a higher burden of 3 
plaque, unidentified through conventional means. Assessment of inflammation 4 
could thus be used to identify high risk individuals for aggressive risk factor 5 
management as is been done in studies such as CANTOS (232), or further 6 
invasive/non invasive investigations.  7 
In conclusion, we observed that South Asians exhibit higher levels of CRP 8 
compared with Europeans. This is independent of cardiovascular risk factors and 9 
atherosclerotic plaque burden as assessed by CAC and MPS. While ongoing studies 10 
including our own will provide data to ascertain the aetiology and prognostic 11 
implications of a higher degree of inflammation among South Asians, it as an 12 
important factor which needs to be addressed in risk stratification and treatment. It 13 
also provides a much needed direction to guide further research into higher CHD in 14 




Table 5.1: Characteristics of participants 1 
 2 
 European (1004) South Asian (1343) P value 
Age (Years) 57±10 55 ±10 <0.001 
Agatston score (95% CI) 153 ± 442 123± 384 0.12 
Gender (Male) 70 61 <0.001 
Log CRP*  1.5 ± 3.5 2.0 ± 3.5 0.008 
Hypertension (%) 19 31 <0.001 
Systolic Blood Pressure (mm Hg) 79 ±10 79 ±10 0.1 
Diastolic Blood Pressure (mm Hg) 129 ± 19  128 ± 19 0.7 
CRP 3.7 3.97  
Body fat (%) 30 ± 8 32± 9 <0.001 
Waist Hip Ratio 0.9 ± 0.09 0.94 ± 0.07 <0.001 
Body Mass index 27±4.7 27±4.2 0.2 
Type 2 diabetes (%) 7 18 <0.001 
Serum Glucose (mmol/l) 5.4± 1.5 5.8 ± 1.9 <0.001 
HbA1c  5.5 ± 0.9 6.1 ±1.2 <0.001 
    
Current smokers (%) 17 7 <0.001 
Ever smoker (%) 53 15 <0.001 
    
Statin Usage (%) 8 16 < 0.001 
Total cholesterol (mmol/l) 5.6 ±1.0 5.3 ±1.1 <0.001 
LDL Cholesterol (mmol/l) 3.5 ± 0.9 3.3 ± 0.9 <0.001 
HDL cholesterol (mmol/l) 1.4 ± 0.4 1.3 ± 0.3 <0.001 
Triglycerides (mmol/l) 1.5  ± 1.1 1.7 ± 1.2 <0.001 
Metabolic syndrome (NCEP) % 20% 29% <0.001 
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Risk factor Odd’s ratio (95% CI) P value 
Age ( 10 Years) 1.01 (1.01, 1.02) <0.001 
Race (SA vs Europeans) 1.31 (1.17, 1.46) <0.001 
Gender (Male vs Female) 1.54 (1.38, 1.72) <0.001 
Hypertension 1.43 (1.27, 1.63) <0.001 
Statin usage 0.98 ( 0.83, 0.87) 0.76 
Type 2 Diabetes Mellitus 1.14 ( 1.04, 1.25) 0.006 
Total cholesterol (mmol/l) 1.07 (1.02, 1.13) 0.11 
HDL Cholesterol (mmol/l) 0.61 ( 0.55, 0.71) <0.001 
LDL cholesterol (mmol/l) 1.07 ( 1.01, 1.14) 0.002 
Triglycerides (mmol/l) 1.14 (1.08, 1.19) <0.001 
HbA1c 1.25 ( 1.19, 1.31) <0.001 
Ever smoker 0.97 (0.86, 1.08) 0.6 
Current smoker CRP 1.07 ( 0.91, 1.28) 0.4 
Waist Hip Ratio 20.49 ( 10.8, 36.6) <0.001 
Body mass index 1.12 (1.11, 1.13) <0.001 
 1 
*log transformation used 2 
 3 
 4 
Univariable linear regression, demonstrating change in CRP, for unit change in risk 5 






Table 5.3  Multivariable regression for predictors of CRP levels 1 
 2 
 3 
Change in odds for increasing CRP per increment in risk factors 4 
estimated using linear regression, adjusted for risk factors listed.  5 
 6 
7 
Risk factor Odds ratio (95% CI) P value 
Age (10 Years) 1.01 (1.0, 1.02) .001 
Race (SA vs Europeans) 1.2 (1.1, 1.4) .002 
Gender (Male vs Female) 1.2 (1.03, 1.53) .021 
Hypertension 1.2 ( 1.01, 1.31) .037 
Statin usage 0.7 (0.6, 0.8) < 0.001 
Type 2 Diabetes Mellitus 0.8 ( 0.6, 1.02) .077 
HDL Cholesterol (mmol/l) 0.7 (0.6, 0.9) .002 
LDL cholesterol (mmol/l) 1.1 (0.99, 1.13) .054 
Triglycerides (mmol/l) 0.9 ( 0.92, 1.07) .959 
HbA1c 1.1 (1.03, 1.25) .011 
Ever smoker 1.1 (0.94, 1.25) .289 
Current smoker 1.3 (1.04, 1.55) .018 
Waist Hip Ratio 3.0 (1.4, 6.4) .005 
Body mass index 1.06 ( 1.04, 1.08) < 0.001 
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Table 5.4  Multivariable regression for predictors of CAC 1 
 2 
Change in odds for increase in log CAC per increment in risk factors 3 
estimated using linear regression, adjusted for risk factors listed.  4 
 5 
6 
Risk factor Odds ratio (95% CI) P value 
Age (10 Years) 1.1 (1.1, 1.2) <.001 
Race (SA vs Europeans) 1.05 (0.8, 1.2) 0.6 
Gender (Male vs Female) 3.9 (2.9, 5.8) <0.001 
Hypertension 1.9 ( 1.6, 2.4) <0.001 
Statin usage 2.1 (1.6, 2.8) < 0.001 
Type 2 Diabetes Mellitus 1.76 ( 1.3, 2.2) <0.001 
HDL Cholesterol (mmol/l) 0.9 (0.9, 1.01) 0.3 
Total cholesterol (mmol/l) 1.02 (1.01, 1.03) <0.001 
Ever smoker 1.2 (0.9, 1.5) 0.12 
Current smoker 1.5 (1.1, 2.0) 0.009 
Waist Hip Ratio 0.96 (0.8, 1.1) 0.5 
Body mass index 1.03 ( 1.01, 1.05) 0.003 
Log CRP 1.04 (0.9, 1.1) 0.2 
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Chapter 6: Limitations, Conclusions and Future Work 1 
 2 
6.1 Limitations 3 
Our study has several potential limitations. Firstly, our study had a response 4 
rate of 36%; while these rates are similar to those seen in population-based studies 5 
such as MESA; they are low and might potentially introduce bias. However, there 6 
were no differences in response rates between South Asians and Europeans. 7 
Secondly, our cohort included a selected asymptomatic group, and potential 8 
participants with known cardiovascular disease were excluded at entry. The study 9 
thus might not accurately reflect the disease process in those with known coronary 10 
artery disease. Thirdly, the study is cross-sectional, and would be affected by 11 
different survival rates among ethnic groups. However, the large population-based 12 
sample, stringent ethnic group classification and standardised assessment give our 13 
study the potential to accurately explore the differences in sub clinical atherosclerosis 14 
between South Asians and Europeans.  15 
 16 
6.2 Conclusions 17 
In this thesis, I have examined markers of subclinical atherosclerosis and 18 
inflammation in a large cohort of unselected asymptomatic individuals of South 19 
Asian and European ethnicity. I have found that: 1) Coronary artery calcification 20 
scores were closely associated with age, male gender, cigarette smoking, 21 
hypertension, systolic blood pressure, diabetes and total cholesterol. 2) There were no 22 
differences in either coronary artery calcification prevalence or mean levels of 23 
coronary artery calcification between South Asian and European, after adjustment for 24 
140 
 
the measured cardiovascular risk factors. 3) Presence of diabetes and increasing 1 
coronary artery calcification were independent predictors for silent myocardial 2 
ischemia. 4) South Asian ethnicity did not influence the prevalence or the extent of 3 
silent myocardial ischemia, after adjustment for conventional risk factors. 5) 4 
Conventional risk factors including obesity, hypertension and diabetes mellitus are 5 
associated with elevated CRP levels. 6) South Asians have a higher degree of 6 
systemic inflammation as measured by serum high sensitivity C-reactive protein 7 
levels, after adjusting for conventional risk factors.  8 
Coronary heart disease (CHD) is the single largest contributor to global 9 
mortality, with more than 13% of all deaths in 2002 attributed to CHD(1). There are, 10 
however, distinct ethnic differences in CHD incidence and mortality. South Asians 11 
(people originating from India, Pakistan, Bangladesh and Sri Lanka) demonstrate 12 
high levels of CHD -attributable mortality.  According to figures released by World 13 
Health Organization, while South Asians currently comprise 22% of the global 14 
population, they accounted for almost a quarter of the global CHD deaths in 2002. 15 
Furthermore, as a result of a high  growth rate this proportion is expected to increase 16 
to  28% by 2050 (2), and with the inherent high CHD risk, South Asians are expected 17 
to contribute to almost 40% of the global CHD burden by 2050 (2).  18 
This rapidly increasing population with a (2) propensity towards CHD 19 
(233,234) especially at younger ages (192) is in stark contrast to the developed world 20 
where slower growth rates are observed (2), alongside reductions in CHD rates 21 
(4,235).  22 
Among South Asians, CHD is closely related to an urbanized lifestyle, with 23 
the highest rates of CHD observed among overseas South Asians (3-10). Within the 24 
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UK, South Asians continue to show a 2-fold higher CHD mortality rate despite 1 
decreasing rates among Local Europeans for the same period (4).  2 
In diseases with a high mortality, population screening has resulted in 3 
decreasing mortality through early identification and treatment (236,237). For 4 
coronary heart disease, screening has traditionally been through two main methods:  5 
a) identification of specific risk factors and b) use of statistically created models to 6 
predict risk of developing disease. Through such screening, we are provided us with 7 
the estimated risk of an individual to develop clinical disease, and therefore tailor the 8 
management of each component and the patient, accordingly. This presents a 9 
challenge when evaluating coronary heart disease among South Asians, for two 10 
important reasons: 11 
First, while CHD among South Asians is not independent of conventional risk 12 
factors (5,238,239), the limited data available suggests that such factors are not 13 
consistently elevated among South Asians, and do not account for the increased 14 
coronary heart disease (CHD) risk in South Asians (7,8,10). Type 2 diabetes mellitus 15 
(T2D) and insulin resistance are more prevalent among South Asians compared with 16 
Europeans, however, studies from UK and Canada have demonstrated that although 17 
presence of diabetes increases mortality risk in South Asians to a greater extent than 18 
in Europeans, the risk of CHD remains elevated after adjustment for traditional risk 19 
factors. (8,47,192).  20 
Thus, if we use risk factors to identify South Asians at higher CHD risk and 21 
treat individual risk factors, it is unclear whether we address the actual risk of 22 
coronary heart disease among this population, and if so, to what extent.  23 
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Second, risk stratification models assign a specific risk of CHD to individuals 1 
within a population, based on the risk factors. This helps ascertain the population at 2 
high risk for CHD, and therefore potentially able to derive maximum benefit from 3 
aggressive risk factor management. However, there are limitations to such models. 4 
There is substantial variation in the amount of atherosclerosis for every level of risk 5 
factor exposure (240), thus it would appear intuitive that it would be so for each risk 6 
category.  Further, coronary events in populations deemed to be at a low risk for CHD 7 
by such models further highlights limitations of such models. While such events are 8 
thought to be consequent to multiple factors including duration of exposure as well as 9 
interactions among risk factors and genetic susceptibility, the risk remains 10 
unaccounted in the risk stratification models.  Additionally, as majority of the cohort 11 
studies forming the basis for scoring systems were originally from risk assessments in 12 
Caucasian populations; their weaknesses are accentuated when employed in other 13 
ethnic groups (241,242). Thus, the failure of risk scores such as the Framingham 14 
function among South Asians (108,243) can be due to a multitude of reasons. 15 
In summary, it appears that while we have a population with a high CHD 16 
mortality, who would benefit from early screening and identification of CHD risk, we 17 
lack the tools to do so.   18 
With increasing awareness of the role of CHD in global mortality rates, there 19 
has been considerable research into the identification of individuals at high risk of 20 
CHD. An important development in this field has been the emergence of techniques 21 
that allow the non-invasive visualization of atherosclerotic plaque.  22 
Coronary artery calcification is a highly sensitive marker of coronary plaque 23 
burden (130,144), and is correlated with histomorphometric plaque burden (r > 24 
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0.90)(130). Prevalence of coronary calcification is significantly higher in subjects 1 
with traditional cardiovascular risk factors such as hypertension, diabetes, obesity, 2 
physical inactivity, previous smoking, and hypercholesterolemia (148,166-169). 3 
Coronary artery calcification provides an incremental value for predicting prognosis 4 
compared with conventional risk factors alone (134,163,164), supporting its role as an 5 
important risk stratification tool. However, the majority of these studies were 6 
conducted in Caucasians groups, and there is scarce understanding about the 7 
prevalence among South Asians.  8 
In the first study, it was shown that age, BMI, current and former smoking, 9 
statin usage, presence of hypertension or diabetes mellitus, male gender and European 10 
ethnicity, as well as serum HDL and triglyceride levels, were associated with elevated 11 
odds for the increasing extent of CAC. After adjusting for conventional 12 
cardiovascular risk factors and ethnicity, age, male gender, current smoking, statin 13 
use, diabetes, hypertension and LDL cholesterol were all positively associated with 14 
increased levels of CAC.   Ethnicity appeared not to influence prevalence or extent of 15 
coronary artery calcification among South Asian compared with European 16 
participants.  17 
These data did not show any differences in CAC between UK South Asians 18 
and Europeans, despite a worse cardiovascular risk profile among South Asians. This 19 
is in contrast to the excess CHD risk observed in South Asian. This study suggests 20 
that the increased prevalence of CHD amongst South Asians is not reflected by their 21 
increased propensity towards atheroma formation, compared with Europeans, and that 22 




 Myocardial perfusion imaging is a technique that has been validated for 1 
functional assessment of flow limiting lesions within coronary arteries. Thus, it 2 
allows quantification of the hemodynamic relevance of the atherosclerotic lesions. This 3 
technique has been validated in studies using coronary angiography and coronary artery 4 
calcification to quantify atherosclerotic plaque (179,244), with increasing ischemia 5 
observed with higher levels of plaque. Data from our group and others has suggested 6 
that when using coronary artery calcification as a marker of plaque, a cut –off of 100 7 
Agatston units increases the specificity of the test. There appears to be a marked 8 
difference in prevalence of ischemia noted above and below this level 9 
(140,179,184,186).  10 
 Based on these data, and in order to assess whether similar plaque calcification 11 
portents greater plaque burden among South Asians, myocardial perfusion imaging was 12 
performed in a cohort of subjects with coronary artery calcification scores greater 13 
than 100 Agatston units. I found that increasing age and higher CAC category, as well 14 
as presence of diabetes, were associated with elevated odds for the presence of 15 
myocardial ischemia among both populations. After adjustment for cardiovascular 16 
risk factors, ethnicity was not related to presence of myocardial ischemia, OR= 0.9 17 
(95% CI 0.4, 2.0). Prevalence and extent of myocardial ischemia increase in parallel 18 
with CAC scores among South Asians and Europeans. There was no significant 19 
ethnic difference in extent or severity of myocardial ischemia.  20 
Anatomical presence and size of atherosclerosis lesions is only a part of the 21 
aetiology of vascular disease with other equally factors involved in the development 22 
of acute thrombotic events. Blood thrombogenecity is equally important in 23 
determining the clinical course of an acute plaque event. To recognise the collective 24 
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importance of these systems it has been proposed that at risk individuals be referred 1 
to as “vulnerable patients” (127). Such risk may be identified through serum markers 2 
of atherosclerosis (abnormal lipoprotein profile), inflammation (high-sensitivity 3 
CRP), metabolic disorders (blood glucose, triglycerides and homocysteine) and 4 
through coagulation disorders (fibrinogen, factor V Leiden, increased coagulation 5 
factors, decreased anticoagulant factors).  6 
Inflammation is one of the key factors in initiating atherosclerosis as well as 7 
the pathogenesis of vulnerable plaques (49). This is supported by studies done in 8 
animal models as well as those among human cases of sudden death, demonstrating 9 
increased macrophage activity in plaques which underwent rupture and subsequent 10 
thrombosis (51). Furthermore, recent studies in human subjects have shown markedly 11 
increased inflammation within active atherosclerotic plaques in carotid arteries 12 
(52,53). Among the markers of inflammation, CRP is one of the most extensively 13 
studied molecules. It is considered an independent predictor of future cardiovascular 14 
events (51,65) improving risk stratification when added to conventional risk factors 15 
(223,224) with increased concentrations of associated with atherothrombotic events. 16 
Elevated levels of CRP are associated with increased macrophage activity within 17 
plaques (63,64) and with a higher density of high risk mixed coronary plaques (221). 18 
Presence of elevated CRP levels in subjects with non calcified plaque has been 19 
associated with an increased incidence of cardiovascular events (222).  20 
Thus, the third study evaluated systemic inflammation measured using CRP 21 
levels. I demonstrated that South Asians had a worse metabolic profile with a higher 22 
prevalence of diabetes mellitus, hypertension and metabolic syndrome. South Asians 23 
demonstrated elevated CRP levels both before and after adjusting for metabolic 24 
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factors, conventional cardiovascular risk factors and measures of obesity. The CRP 1 
levels were not significantly associated with markers of atherosclerosis, including 2 
CAC and MPS, in either ethnicity.  3 
These are vital studies for increasing understanding of CHD among South 4 
Asians and have several important implications. Through the course of this project I 5 
have demonstrated that South Asians have similar atherosclerotic plaque burden as 6 
assessed by CAC and MPS, however, have a higher degree of systemic inflammation. 7 
This is unexplained by conventional risk factors, and is does not explain or correlate 8 
with atherosclerotic burden. Thus, while the total atherosclerotic burden is the same 9 
in the two populations; there are higher levels of systemic inflammation and 10 
prothrombotic factors in Indians Asians compared with European. The higher CHD 11 
risk among South Asians could therefore be a result of a higher propensity to plaque 12 
rupture or undergo thrombosis.   13 
These results stress the importance of factors such as vulnerability or 14 
inflammation within atherosclerotic plaque as potential explanations for the elevated 15 
coronary events and CHD mortality among South Asians. They also generate several 16 
important questions for future studies, and avenues of treatment.(232) 17 
 18 
6.3 Future work 19 
 20 
 21 




Previous studies have suggested the addition of ethnicity based weighing 26 
factors and cut offs as “correction factors” for improving tools such as metabolic 27 
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syndrome (245) and Framingham risk scores (241,243). The follow-up from this 1 
study will allow assessment of the prognostic significance of coronary artery 2 
calcification for South Asians, i.e. do South Asians have similar mortality as 3 
Europeans for comparable levels of calcification or is the mortality among South 4 
Asians higher or lower than Europeans for any given level of calcification. It will 5 
help decide whether frequently used cut off levels for CAC such as >100, > 400 6 
suggest the same prognostic significance for South Asians as for EW; or do we need 7 
to define ethnic specific categories. Thus, it will guide us towards more effective use 8 
of coronary artery calcification imaging as a tool for risk stratification among South 9 
Asians. 10 
Therefore, cohort surveillance and follow-up for clinical events will form an 11 
essential component of the long term goal for this study. Study event endpoints will 12 
include acute myocardial infarction and other forms of CHD, peripheral vascular 13 
disease, congestive heart failure, coronary interventions and mortality. The follow-up 14 
of enrolled subjects is to be undertaken at Ealing Hospital by trained research nurses. 15 
The first follow-up contact commenced in January 2010 and is to be repeated in 16 
2015.The NHS number and other demographic details will be used to link to health 17 
records and multiple sources (Office for National Statistics, Virtual Organisation for 18 
Trials and Epidemiological Studies, Hospital Episode Statistics data and clinical 19 







6.3.2 Assessment of inflammatory or vulnerable plaque  1 
Traditionally, intravascular ultrasound has been the gold standard for 2 
evaluating total atherosclerotic plaque burden of the coronary arteries. Studies 3 
have used this technology to identify the morphological characteristics of coronary 4 
artery plaque lesions that are responsible for acute coronary events (121).
 
5 
However, one disadvantage with intravascular ultrasound is that it can be only 6 
performed during invasive coronary angiography. 7 
Recent advances in imaging, including dual source CT technology, show 8 
extremely promising results, with CT coronary angiography providing non-9 
invasive information about the vessel wall and morphology of plaque lesions, 10 
similar to that afforded by intravascular ultrasound (246-248). Recent prospective 11 
studies using CT coronary angiography have demonstrated  the role of `spotty 12 
calcification’ (seen on CT coronary angiography) in rendering a plaque lesion 13 
more prone for rupture (203). Furthermore, recent studies have been also been able 14 
to characterize atherosclerotic coronary plaque lesions with a thin fibrous cap and 15 
a necrotic lipid core, the “vulnerable plaque” as having distinctive `napkin-ring’ 16 
appearance on CT coronary angiography. (249).  Such morphological 17 
characteristics detected with non- invasive angiography will allow delineation of 18 
plaque composition and thus imaging of vulnerable plaque; a step closer to the 19 
identification of patients at higher risk of suffering an acute coronary event. 20 
Studying South Asians with techniques such as these will help us 21 
understand the pathogenesis of CHD, as well as the mechanisms behind the high 22 




6.3.3 Evaluation of markers of systemic inflammation and pro thrombotic 1 
factor  2 
The third important factor along with plaque burden and plaque composition 3 
is the atherothrombotic state. Although not capable of conveying the actual burden of 4 
atherosclerosis, there are several emerging blood biomarkers that may be useful in 5 
enhancing risk stratification and prognosis of CHD.  6 
Atherogenesis is characterised by the presence of local inflammation which is 7 
believed to lead to plaque vulnerability, thus predisposing it to rupture causing 8 
arterial thrombosis (48). Prospective studies in healthy subjects have demonstrated an 9 
independent association between elevated concentrations of systemic inflammation 10 
and vascular events. Among such markers of inflammation, high-sensitivity CRP, an 11 
acute phase reactant, has been extensively studied. It is an extremely sensitive marker 12 
of inflammation, and increased concentrations of this marker have predicted 13 
cardiovascular outcomes independent of concomitant risk factors (250-252). Elevated 14 
levels of CRP have been observed in a healthy population of South Asians compared 15 
with Europeans while being closely related with central obesity in both populations 16 
(60). 17 
Markers of inflammation such as IL-6 (253,254), and pentraxin-3 (255)in the 18 
plasma have also been shown to correlate with cardiovascular events. In a prospective 19 
study of 510 asymptomatic diabetic patients, levels of osteoprotegerin, a cytokine of 20 
the tumour necrosis factor receptor super-family, were associated with prevalence of 21 
sub-clinical atherosclerosis and short-term cardiovascular events (148). The possible 22 
correlation between RANKL, a member of the TNF ligand family for which 23 
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osteoprotegerin is a decoy receptor, and acute coronary syndromes has been reported 1 
(199).  2 
Lipoprotein (a) is composed of a cholesterol rich particle linked to a 3 
glycoprotein of variable size called apolipoprotein (a). High levels of Lipoprotein (a) 4 
have been shown to be a risk factor for CVD, with levels above 30mg/dL shown to 5 
increase risk by two to three times in Caucasian populations (256). The association of 6 
Lipoprotein (a) with CAD and its ability to act as a biomarker of risk appears to be 7 
strongest in patients with hypercholesterolemia and particularly in young patients 8 
with premature atherosclerosis. 9 
Thus, evaluation of such factors could provide both an insight into 10 
mechanisms of coronary disease in Indians Asians, and also provide markers to help 11 
quantify risk of CHD among South Asians. 12 
All subjects enrolled into the study provided blood samples which were frozen 13 
and analysis has recently been completed for appropriate biomarkers of subclinical 14 
CVD, relating to inflammation, lipoprotein sub particles. 15 
  16 
6.3.4 Potential risk stratification tools 17 
South Asians appear to be at a high risk of CHD, compared with other ethnic 18 
groups. Conventional risk factors, while identifying subjects at a risk of CHD, fail to 19 
identify this excess risk in South Asians. While markers of atherosclerotic plaque 20 
burden do not appear to identify the high risk of coronary heart disease mortality 21 
among South Asians, they do identify a group at a higher risk than the general 22 
population. Bio- markers such as CRP, IL-6, osteoprotegerin and NT-pro BNP among 23 
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others have been demonstrated to be associated with a higher risk of acute coronary 1 
events, and help identify/ stratify subjects at a high risk of CHD, and related events. 2 
Thus, a potential risk stratification tool should reflect the multisystem nature 3 
of CHD. This could be a combination of markers of its risk factors which contribute 4 
towards CHD, imaging of atherosclerotic plaque and assessment of plaque or 5 





6.4 Summary 1 
Obstructive coronary artery disease and resulting ischemia is a consequence of 2 
luminal narrowing secondary to large atherosclerotic plaques. These plaques consist 3 
of calcified and non calcified deposits. While coronary calcification measures 4 
calcified plaque, myocardial perfusion imaging is a marker of flow limiting 5 
obstruction and thus, of total plaque burden. In this thesis I have demonstrated similar 6 
calcified plaque burden, along with similar extent of myocardial ischemia among 7 
South Asians compared with Europeans, despite their high coronary heart disease 8 
mortality. I have also demonstrated higher degree of systemic inflammation among 9 
South Asians. The similar prevalence of markers of atherosclerotic plaque burden, 10 
with higher degree of inflammation among South Asians compared with Europeans 11 
suggest an important role of inflammation in the excess risk for coronary heart 12 
disease among South Asians.  13 
Future studies should therefore be aimed at evaluating the role of 14 
inflammation within plaque, systemic inflammation as well as pro thrombotic factors 15 
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